What changed in this filing

/stocks — the workspaceLOADING

Item 9A. Controls and Procedures

2021-03-31 compared with 2020-03-03 · 694 added, 1031 removed, 230 unchanged (88% of the section changed)

CONTROLS AND PROCEDURES

controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be

disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s

management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate

to allow timely decisions regarding required disclosure.

of Disclosure Controls and Procedures

carried out an evaluation, under the supervision and with the participation of our management, including our chief executive

officer (our principal executive officer) and our chief financial officer (our principal financial and accounting officer),

of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period

covered by this report.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer (our principal executive officer) and our chief financial officer (our principal financial and accounting officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report.

The evaluation was undertaken in consultation with our accounting personnel.

Based on that

evaluation, our chief executive officer and our chief financial officer concluded that as of December 31, 2019, our

disclosure controls and procedures are not effective to ensure that information required to be disclosed by us in the reports

that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods

specified in the Securities and Exchange Commission’s rules and forms.

on Internal Control over Financial Reporting

management is responsible for establishing and maintaining internal control over financial reporting.

Internal control over financial

reporting is defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the

supervision of, our principal executive and principal financial officers and effected by our Board, management and other personnel,

to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for

external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

pertain to the maintenance

of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

provide reasonable

assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally

accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations

of management and our directors;

provide reasonable

assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could

have a material effect on the financial statements.

of its inherent limitations, our internal control over financial reporting may not prevent or detect misstatements.

even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation

and presentation.

Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become

inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

principal executive officer and our principal financial officer assessed the effectiveness of our internal control over financial

reporting as of December 31, 2019.

In making this assessment, management used the criteria set forth by the Committee of Sponsoring

Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework issued in 2013.

In connection with

that assessment, our principal executive officer and principal financial officer have determined that there was a material

weakness in our internal control over financial reporting as a result of a determination following initial assessment that

the documentation underlying the preparation of forward projections which included copies of customer contracts underlying

the basis of projecting revenues and support for the projected cost structures associated with determining the fair value of

the Sysorex note as of December 31, 2019 was not sufficient evidence thereby requiring material adjustments to be made to the

carrying value of the note as initially determined by management as of December 31, 2019.

A “material weakness”

is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a

reasonable possibility that a material misstatement of our annual or interim financial statements would not be prevented or

detected on a timely basis.

We cannot assure you that we will adequately remediate the material weakness or that additional

material weaknesses in our internal control will not be identified in the future.

Any failure to maintain or implement

required new or improved controls or any difficulties we encounter in their implementation could result in additional

material weaknesses or could result in material misstatements in our financial statements.

on the assessment, our principal executive officer and our principal financial officer determined that, as of December 31, 2019,

our internal control over financial reporting is not effective.

Remediation Plan for Material Weakness

in Internal Control

We are in the process

of developing certain remediation steps to address the previously disclosed material weakness discussed above and to improve our

internal control over financing reporting.

We expect to complete our remediation process on or about the end of the first quarter

of fiscal 2020.

The Company and the Board take the control and integrity of our financial statements seriously and believe that

the remediation steps described below are essential to maintaining a strong internal control environment.

As a result, we will

enhance our internal technical accounting capabilities augmented by the use of third-party advisors and consultants to assist

with areas requiring specialized technical accounting expertise and reviewed by management.

We are committed to maintaining a strong internal control environment,

and believe that these remediation actions will represent significant improvements in our controls.

However, the identified weakness

in internal control over financial reporting will not be considered remediated until controls have been designed and/or controls

are in operation for a sufficient period of time for our management to conclude that the material weakness has been remediated.

Additional remediation remedies may be required, which may require additional implementation time.

We will continue to assess the

effectiveness of our remediation efforts in connection with our evaluations of internal control over financial reporting.

in Internal Control over Financial Reporting

have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15 (f)

under the Exchange Act) during the fourth quarter of the last fiscal year that have materially affected, or are reasonably likely

to materially affect, our internal control over financial reporting.

Based on that evaluation, our chief executive officer and our chief financial officer concluded that as of December 31, 2020, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining internal control over financial reporting.

Internal control over financial reporting is defined in Rule 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our Board, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

• pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;

• provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of management and our directors;

• provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

Because of its inherent limitations, our internal control over financial reporting may not prevent or detect misstatements.

Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In connection with our annual report on Form 10-K for the year ended December 31, 2019, we reported a material weakness in our internal control over financial reporting resulting from the determination following initial audit procedures that the documentation underlying the preparation of forward projections, which included copies of customer contracts underlying the basis of projecting revenues and support for the projected cost structures associated with determining the fair value of the Sysorex Note as of December 31, 2019, was not sufficient thereby requiring material adjustments to be made to the carrying value of the Sysorex Note as determined by management as of December 31, 2019.

To address the material weakness, during the year ended December 31, 2020, we enhanced our internal technical accounting capabilities by engaging and using third-party advisors to assist in areas requiring specialized technical accounting expertise, including with respect to designing the procedures and processes associated with assessing the fair value of our equity and debt instruments.

We have tested these

measures and believe these measures have enabled us to remediate the underlying control deficiency that gave rise to the previously disclosed material weakness.

Following such remediation, our principal executive officer and our principal financial officer assessed the effectiveness of our internal control over financial reporting as of December 31, 2020.

In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework issued in 2013.

Based on the assessment, our principal executive officer and our principal financial officer determined that, as of December 31, 2020, our internal control over financial reporting is effective.

Changes in Internal Control over Financial Reporting

There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15 (f) under the Exchange Act) during the fourth quarter of the last fiscal year that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

OTHER INFORMATION

The information

set forth below is included herein for the purpose of providing the disclosure required under “Item 1.01 –

a Material Definitive Agreement.”

At-The-Market (ATM) Program

On March 3, 2020,

we entered into an Equity Distribution Agreement (the “Sales Agreement”) with Maxim Group LLC (“Maxim”)

under which we may offer and sell shares of our common stock having an aggregate offering price of up to $50 million (the “Shares”)

from time to time through Maxim, acting exclusively as our sales agent (the “Offering”).

The Company intends to use

the net proceeds of the Offering primarily for working capital and general corporate purposes.

We may also use a portion of the

net proceeds to invest in or acquire businesses or technologies that we believe are complementary to our own, although we have

no current plans, commitments or agreements with respect to any acquisitions as of the date of this Annual Report on Form 10-K.

Any Shares offered and sold in the Offering will be issued pursuant to the Company’s Registration Statement on Form S-3 (File

333-223960) filed with the Securities and Exchange Commission on March 27, 2018, as amended on May 15, 2018 and declared effective

on June 5, 2018 (the “Form S-3”), the base prospectus dated June 5, 2018 included in the Form S-3 and the prospectus

supplement relating to the Offering to be filed with the SEC on or about March 3, 2020.

Sales of the Shares

through Maxim, if any, will be made by any method that is deemed an “at the market”

offering as defined in Rule 415

under the Securities Act of 1933, as amended, including sales made directly on the Nasdaq Capital Market, or any other existing

trading market for our common stock or to or through a market marker.

Maxim may also sell the Shares by any other method permitted

by law, including in privately negotiated transactions.

Maxim will also have the right, in its sole discretion, to purchase Shares

from the Company as principal for its own account at a price and subject to the other terms and conditions agreed upon at the time

Maxim will use its commercially reasonable efforts, consistent with its sales and trading practices, to solicit offers

to purchase the Shares under the terms and subject to the condition set forth in the Sales Agreement.

We will pay Maxim commissions,

in cash, for its services in acting as agent in the sale of the Shares.

Maxim will be entitled to compensation at a fixed commission

rate of 4.0% of the gross sales price per Share sold.

In addition, the Company has agreed to reimburse Maxim for its costs and

out-of-pocket expenses incurred in connection with its services, including the fees and out-of-pocket expenses of its legal counsel.

We are not obligated

to make any sales of the Shares under the Sales Agreement and no assurance can be given that we will sell any Shares under the

Sales Agreement, or if we do, as to the price or amount of Shares that we will sell, or the dates on which any such sales will

The Sales Agreement will continue until the earliest of (i) twelve (12) months following the date of the Sales Agreement,

(ii) the sale of Shares having an aggregate offering price of $50 million, and (iii) the termination by either the Agent or the

Company upon the provision of 15 days written notice or otherwise pursuant to the terms of the Sales Agreement.

The foregoing description

of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Sales

Agreement, a copy of which is filed as Exhibit 1.1 hereto and is incorporated herein by reference.

A copy of the opinion of Mitchell

Silberberg & Knupp LLP, counsel to the Company, relating to the validity of the shares of common stock to be issued in the

Offering, is filed as Exhibit 5.1 hereto.

This disclosure shall

not constitute an offer to sell or the solicitation of any offer to buy the securities discussed herein, nor shall there be any

offer, solicitation or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to

registration or qualification under the securities laws of any such state.

Fourth Amendment to Sysorex Loan Documents

2020, we entered into a fourth amendment agreement (the “Fourth Amendment Agreement”) with Sysorex, Inc.

(“Sysorex”)

in connection with that certain Note Purchase Agreement, dated as of December 31, 2018 (as amended from time to time in accordance

with its terms, the “NPA”), and that certain Secured Promissory Note issued to us by Sysorex on December 31, 2018

(as amended from time to time in accordance with its terms, the “Note,”

together with the NPA, the “Sysorex

Loan Documents”).

Pursuant to the Fourth Amendment Agreement, the Sysorex Loan Documents were amended to extend the maturity

date from December 31, 2020 to December 31, 2022, to increase the default interest rate from 18% to 21% or the

maximum rate allowable by law and to require a cash payment to the Company by Sysorex against the Loan Amount in an amount equal

to no less than 6% of the aggregate gross proceeds raised following the completion of any financing, or series of related financings,

in which Sysorex raises aggregate gross proceeds of at least $5 million.

Nadir Ali, our Chief Executive Officer and a member of our Board of Directors,

is also on the Board of Directors of Sysorex.

The transactions disclosed herein were unanimously approved by our Board of Directors.

The foregoing description

of the Fourth Amendment Agreement does not purport to be complete and is qualified in its entirety by reference to the full text

of the Fourth Amendment Agreement, a copy of which is filed as Exhibit 10.46 hereto and is incorporated herein by reference.

The disclosure set forth below is provided in connection with Item 1.01, Item 2.03 and Item 3.02.

Stock Purchase Agreement

On March 25, 2021 (the “Signing Date”), we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Game Your Game, Inc., a Delaware corporation (“GYG”), Rick Clemmer (“Clemmer”) and Martin Manniche who is also a director of GYG (“Manniche,” and, together with Clemmer, the “Sellers”), pursuant to which we will acquire an aggregate of 522,000 shares of common stock of GYG (the “Purchased Shares”), representing 52.2% of the outstanding shares of common stock of GYG on a fully diluted basis, on the terms and subject to the satisfaction of the conditions set forth in the Purchase Agreement (the “Acquisition”).

GYG’s business consists of developing and providing solutions using sports data and analytics.

All defined terms used herein and not otherwise defined have the meanings set forth in the Purchase Agreement.

Subject to the terms and conditions of the Purchase Agreement, we will acquire the Purchased Shares as follows:

(i) 283,473 Purchased Shares from GYG in exchange for $1,666,932 in cash (the “Cash Consideration”), and (ii) 238,527 Purchased Shares from the Sellers, in exchange for a number of our shares of common stock, par value $0.001 per share, equal to $1,403,103 divided by the lesser of (A) the closing price per share of our common stock, as reported by the Nasdaq Stock Market, immediately prior to the Closing and (B) the average closing price of Inpixon’s common stock, as reported by the Nasdaq Stock Market, for the 5 trading days immediately preceding the Closing (the “Buyer Shares,” and, together with the Cash Consideration, the “Purchase Price”).

The Cash Consideration will be used for working capital purposes and to satisfy certain outstanding payroll obligations of GYG.

We intend to issue the Buyer Shares in reliance upon an exemption from registration under Section 4(a)(2) of the Securities Act.

The Closing of the Acquisition will be subject to a number of closing conditions, including the entry into or delivery of certain ancillary agreements and documents by the parties, such as the Stockholders’ Agreement (as defined below), as well as other closing conditions customary for transactions of this type.

We anticipate that all closing conditions will be satisfied or waived on or around April 1, 2021;

however, there can be no assurance that the closing conditions will be satisfied or waived or that other events will not intervene to delay or result in the failure to close.

The Purchase Agreement includes representations, warranties and covenants made by the parties that are customary for agreements of this type.

The Sellers and/or GYG will be required to indemnify us for breaches of their representations and warranties, breaches of certain covenants, and for losses arising out of other specified matters, in each case, to the extent set forth and as more fully described in the Purchase Agreement.

Such indemnification obligations are subject to a cap equal to the amount of the Purchase Price, except in cases of the Sellers’ and/or GYG’s fraud or breaches of certain specified representations and warranties.

In addition, we will be entitled to certain information rights with respect to GYG’s financials, certain inspection rights with respect to GYG’s properties and books and records and anti-dilution protection in the event GYG issues additional shares of capital stock.

The Purchase Agreement contains certain customary termination rights, including, among others, (i) the right to terminate the Purchase Agreement prior to the Closing for GYG’s or the Sellers’ breach of any representations, warranties, agreements or covenants, subject to a 30 day cure period, and (ii) the right to terminate the Purchase Agreement if the Closing has not occurred within 120 days of the Signing Date, provided that such failure to close is not the result of the terminating party’s breach of the Purchase Agreement.

The foregoing description of the Purchase Agreement does not purport to be a complete description of the rights and obligations of the parties thereunder and is qualified in its entirety by reference to the full text of the Purchase Agreement, a copy of which is attached hereto as Exhibit 2.23 to this Annual Report on Form 10-K and is incorporated herein by reference.

Other Agreements

The Purchase Agreement contemplates the execution of additional agreements and instruments, on or before the Closing, including, among others, the following:

Board Adviser Agreement

On the Signing Date, we entered into a Board Adviser Agreement (the “Adviser Agreement”) with Clemmer, under which Clemmer will serve as a member of our newly-formed advisory board and provide advice to our board of directors with respect to certain matters relating to our business.

Stockholders’ Agreement

In connection with the Closing, the Company will enter into a Stockholders’ Agreement (the “Stockholders’ Agreement”) with GYG and certain other stockholders of GYG, including the Sellers and such stockholders identified on Exhibit A of the Stockholders' Agreement (collectively, the “Minority Stockholders”).

Pursuant to the terms of the Stockholders’ Agreement, the Minority Stockholders will vote their shares to (i) ensure that GYG’s board of directors is comprised of one director and (ii) elect the person we designate from time to time to serve as GYG’s sole director.

The Stockholders’ Agreement will impose certain transfer restrictions on the Minority Stockholders, with limited exceptions for Minority Stockholders other than the Sellers.

In addition, we will be entitled to a right of first refusal in the event a Minority Stockholder wants to transfer shares to a third party, as well as customary drag-along rights in the event a third party offers to purchase all of GYG’s outstanding capital stock.

The Stockholders’ Agreement will also grant us an option (the “Purchase Option”) to purchase all of the remaining outstanding capital stock, on a fully diluted basis, of GYG (the “Remaining Shares”).

The Purchase Option will be exercisable by us at any time prior to the 3 rd anniversary of the Closing of the Acquisition.

Upon exercise of the Purchase Option, we will be entitled to purchase the Remaining Shares for an aggregate purchase price of $7,170,000, subject to a downward adjustment if GYG is unable to achieve certain financial-based performance targets during a specified period of time.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

following table sets forth the names and ages of all of our current directors and executive officers.

Our officers are appointed

by, and serve at the pleasure of, the Company’s Board of Directors (referred to herein as the “Board”) and/or

our Chief Executive Officer.

Chief Executive Officer and Director

Chief Operating Officer and Chief Marketing

Wendy Loundermon

Chief Financial

Officer and Secretary of Inpixon and Secretary of Inpixon Canada, Inc.

Leonard Oppenheim

Tanveer Khader

Ali has served

as our Chief Executive Officer and as a member of our Board since September 2011.

As the Chief Executive Officer of Inpixon,

The following table sets forth the names and ages of all of our current directors and executive officers.

Our officers are appointed by, and serve at the pleasure of, the Company’s Board of Directors (referred to herein as the “Board”) and/or our Chief Executive Officer.

Name Age Position

Nadir Ali 52 Chief Executive Officer and Director

Soumya Das 48 Chief Operating Officer

Tyler Hoffman 51 Chief Revenue Officer

Wendy Loundermon 50 Chief Financial Officer and Secretary of Inpixon and Secretary of Inpixon Canada, Inc.

Leonard Oppenheim 74 Director

Kareem Irfan 60 Director

Tanveer Khader 52 Director

Ali has served as our Chief Executive Officer and as a member of our Board since September 2011.

As the Chief Executive Officer of Inpixon, Mr.

Ali is responsible for establishing the vision, strategy and the operational aspects of Inpixon.

Ali works with the Inpixon

executive team to deliver both operational and strategic leadership and has over 20 years of experience in the consulting and

high-tech industries.

Ali works with the Inpixon executive team to deliver both operational and strategic leadership and has over 20 years of experience in the consulting and high-tech industries.

From November 2015 until the completion of the Spin-off in August 2018, Mr.

Ali served as the Chief

Executive Officer of Sysorex Inc.

Ali served as the Chief Executive Officer of Sysorex Inc.

SYSX) and continues to serve on its board of directors.

From 1998 to 2001,

From 1998 to 2001, Mr.

Ali was the co-founder and Managing Director of Tira Capital, an early stage technology fund.

2 unchanged sentences

From 1995 through 1998, Mr.

Ali was Vice President of Strategic Programs at Sysorex Information Systems, a computer systems integrator,

which was acquired by Vanstar Government Systems in 1997.

Ali received a Bachelor of Arts degree in Economics from the University

of California at Berkeley in 1989.

Ali’s valuable entrepreneurial, management, mergers and acquisitions and technology

experience together with his in-depth knowledge of the business of Inpixon led us to the conclusion that he should serve as a

member of our Board.

Das has served

as our Chief Marketing Officer since November 2016 and as our Chief Operating Officer since February 2018.

Prior to joining Inpixon,

from November 2013 until January 2016, Mr.

Ali was Vice President of Strategic Programs at Sysorex Information Systems, a computer systems integrator, which was acquired by Vanstar Government Systems in 1997.

Ali received a Bachelor of Arts degree in Economics from the University of California at Berkeley in 1989.

Ali’s valuable entrepreneurial, management, mergers and acquisitions and technology experience together with his in-depth knowledge of the business of Inpixon led us to the conclusion that he should serve as a member of our Board.

Das has served as our Chief Operating Officer since February 2018 and served as our Chief Marketing Officer from November 2016 until March 2021.

Prior to joining Inpixon, from November 2013 until January 2016, Mr.

Das was the Chief Marketing Officer of Identiv, a security technology company.

January 2012 until October 2013, Mr.

Das was the Chief Marketing Officer of SecureAuth, a provider of multi-factor authentication,

single sign-on, adaptive authentication and self-services tools for different applications.

From January 2012 until October 2013, Mr.

Das was the Chief Marketing Officer of SecureAuth, a provider of multi-factor authentication, single sign-on, adaptive authentication and self-services tools for different applications.

Prior to joining SecureAuth, Mr.

was the Vice President, Marketing and Strategy of CrownPeak, a provider of web content management solutions, from April 2010 until

January 2012.

Das earned an MBA from Richmond College, London, United Kingdom, and Bachelor of Business Management from Andhra

University in India.

Loundermon, who

was appointed our Principal Financial and Accounting Officer on July 19, 2017, has overseen all of Inpixon’s finance, accounting

and HR activities from 2002 until October 2014 at which time she became the Vice President of Finance until December 2014.

Das was the Vice President, Marketing and Strategy of CrownPeak, a provider of web content management solutions, from April 2010 until January 2012.

Das earned an MBA from Richmond College, London, United Kingdom, and Bachelor of Business Management from Andhra University in India.

Tyler Hoffman

Hoffman has served as our Chief Revenue Officer since May 2020.

Prior to joining Inpixon, from January 2018 until January 2020, Mr.

Hoffman was Vice President of Enterprise Sales, North America for Visa, Inc.

From November 2016 until January 2018, Mr.

Hoffman served as a consultant to early stage companies with a focus on sales and execution.

From December 2015 until November 2016, Mr.

Hoffman served as Vice President of Sales for Ticketfly, a division of Pandora providing technology and services for live events.

Prior to Ticketfly, Mr.

Hoffman was Vice President of Sales at Quid, Inc., a software platform specializing in machine learning and augmented intelligence, from May 2014 to May 2015.

Hoffman received a Bachelor of Arts degree in humanities with honors from the University of Oregon.

Wendy Loundermon

Loundermon, who was appointed our Principal Financial and Accounting Officer on July 19, 2017, has overseen all of Inpixon’s finance, accounting and HR activities from 2002 until October 2014 at which time she became the Vice President of Finance until December 2014.

From January 2015 and October 2015, she was appointed Interim CFO of the Company.

Thereafter, she continued with the Company as

Vice President of Finance and was re- appointed as CFO on September 16, 2019.

She was also appointed as a member of our Board

on May 14, 2019.

Thereafter, she continued with the Company as Vice President of Finance and was re- appointed as CFO on September 16, 2019.

She was also appointed as a member of our Board on May 14, 2019.

Loundermon has over 20 years of finance and accounting experience.

She is currently responsible for the preparation

and filing of financial statements and reports for all companies, tax return filings, and managing the accounting staff.

received a Bachelor of Science degree in Accounting and a Master of Science degree in Taxation from George Mason University.

Loundermon’s extensive knowledge about the Company and strong financial experience provides her with the qualifications

and skills to serve as a director of our Company.

She is currently responsible for the preparation and filing of financial statements and reports for all companies, tax return filings, and managing the accounting staff.

Loundermon received a Bachelor of Science degree in Accounting and a Master of Science degree in Taxation from George Mason University.

Loundermon’s extensive knowledge about the Company and strong financial experience provides her with the qualifications and skills to serve as a director of our Company.

Oppenheim has served as a member of our Board since July 2011.

Oppenheim retired from business in 2001 and has since been

active as a private investor.

From 1999 to 2001, he was a partner in Faxon Research, a company offering independent research to

professional investors.

Oppenheim retired from business in 2001 and has since been active as a private investor.

From 1999 to 2001, he was a partner in Faxon Research, a company offering independent research to professional investors.

From 1983 to 1999, Mr.

Oppenheim was a principal in the Investment Banking and Institutional Sales division

of Montgomery Securities.

Oppenheim was a principal in the Investment Banking and Institutional Sales division of Montgomery Securities.

Prior to that, he was a practicing attorney.

Oppenheim is a graduate of New York University Law

Oppenheim is a graduate of New York University Law School.

Oppenheim served on the Board of Apricus Biosciences, Inc.

APRI), a publicly held bioscience company, from

June 2005 to May 2014.

Oppenheim’s public company board experience is essential to the Company.

Oppenheim also

meets the Audit Committee Member requirements as a financial expert.

Oppenheim’s public company board experience and

financial knowledge provide him with the qualifications and skills to serve as a director of our Company.

APRI), a publicly held bioscience company, from June 2005 to May 2014.

Oppenheim’s public company board experience is essential to the Company.

Oppenheim also meets the Audit Committee Member requirements as a financial expert.

Oppenheim’s public company board experience and financial knowledge provide him with the qualifications and skills to serve as a director of our Company.

Irfan has served as a member of our Board since July 2014.

Since 2014, Mr.

Irfan has been the CEO (Global Businesses) of Cranes

Software International (Cranes), a business group offering business intelligence, data analytics and engineering software solutions

and services.

Irfan has been the CEO (Global Businesses) of Cranes Software International (Cranes), a business group offering business intelligence, data analytics and engineering software solutions and services.

Previously, Mr.

Irfan was Chief Strategy Officer at Cranes starting in 2011.

From 2005 until 2011, he was General

Counsel at Schneider Electric, a Paris-based global company that specializes in electricity distribution, automation and energy

management solutions.

Irfan served earlier as Chief IP & IT Counsel at Square D Co., a US-based electrical distribution

and automation business, and also practiced law at two international IP law firms in Chicago.

Irfan is a graduate of DePaul

University College of Law, holds a MS in Computer Engineering from the University of Illinois, and a BS in Electronics Engineering

from Bangalore University.

Irfan’s extensive experience in advising information technology companies, managing corporate

governance and regulatory management policies, and over fifteen years of executive management leadership give him strong qualifications

and skills to serve as a director of our Company.

From 2005 until 2011, he was General Counsel at Schneider Electric, a Paris-based global company that specializes in electricity distribution, automation and energy management solutions.

Irfan served earlier as Chief IP & IT Counsel at Square D Co., a US-based electrical distribution and automation business, and also practiced law at two international IP law firms in Chicago.

Irfan is a graduate of DePaul University College of Law, holds a MS in Computer Engineering from the University of Illinois, and a BS in Electronics Engineering from Bangalore University.

Irfan’s extensive experience in advising information technology companies, managing corporate governance and regulatory management policies, and over fifteen years of executive management leadership give him strong qualifications and skills to serve as a director of our Company.

Khader has served as a member of our Board since July 2014.

Since 2010, Mr.

Khader has been the Executive Vice President of Systat

Software Inc., a company offering scientific software products for statisticians and researchers.

Prior thereto he was Senior

Vice President from 2008-2010, Vice President from 2004-2008, and General Manager from 2002-2004.

Khader holds a BE in Engineering

from Bangalore University and a degree in Business Administration from St.

Joseph’s Commerce College.

Khader’s

extensive experience with software development, data analytics and strategic planning give him the qualifications and skills to

serve as director of our Company.

Board may establish the authorized number of directors from time to time by resolution.

The current authorized number of directors

Our current directors, if elected, will continue to serve as directors until the next annual meeting of stockholders

and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal.

continue to review our corporate governance policies and practices by comparing our policies and practices with those suggested

by various groups or authorities active in evaluating or setting best practices for corporate governance of public companies.

Based on this review, we have adopted, and will continue to adopt, changes that the Board believes are the appropriate corporate

governance policies and practices for our Company.

Board held 9 meetings during 2019 and acted through 19 written consents.

No member of our Board attended fewer than 75% of the

aggregate of (i) the total number of meetings of the Board (held during the period for which he or she was a director) and (ii)

the total number of meetings held by all committees of the Board on which such director served (held during the period that such

director served).

Khader has been the Executive Vice President of Systat Software Inc., a company offering scientific software products for statisticians and researchers.

Prior thereto he was Senior Vice President from 2008-2010, Vice President from 2004-2008, and General Manager from 2002-2004.

Khader holds a BE in Engineering from Bangalore University and a degree in Business Administration from St.

Joseph’s Commerce College.

Khader’s extensive experience with software development, data analytics and strategic planning give him the qualifications and skills to serve as director of our Company.

Board of Directors

Our Board may establish the authorized number of directors from time to time by resolution.

The current authorized number of directors is seven.

Our current directors, if elected, will continue to serve as directors until the next annual meeting of stockholders and until his or her successor has been elected and qualified, or until his or her earlier death, resignation, or removal.

We continue to review our corporate governance policies and practices by comparing our policies and practices with those suggested by various groups or authorities active in evaluating or setting best practices for corporate governance of public companies.

Based on this review, we have adopted, and will continue to adopt, changes that the Board believes are the appropriate corporate governance policies and practices for our Company.

Our Board held 9 meetings during 2020 and acted through 8 written consents.

No member of our Board attended fewer than 75% of the aggregate of (i) the total number of meetings of the Board (held during the period for which he or she was a

director) and (ii) the total number of meetings held by all committees of the Board on which such director served (held during the period that such director served).

Members of our Board are invited and encouraged to attend our annual meeting of stockholders.

determining the independence of our directors, we apply the definition of “independent director”

provided under the

listing rules of Nasdaq.

Pursuant to these rules, the Board has determined that all of the directors currently serving on the

Board are independent within the meaning of Nasdaq Listing Rule 5605 with the exception of Nadir Ali and Wendy Loundermon, who

are executive officers.

Board has three standing committees:

the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance

Audit Committee consists of Leonard Oppenheim, Tanveer Khader, and Kareem Irfan, all of whom are “independent”

defined under section 5605(a)(2) of the Nasdaq Listing Rules.

Independence of Directors

In determining the independence of our directors, we apply the definition of “independent director” provided under the listing rules of Nasdaq.

Pursuant to these rules, the Board has determined that all of the directors currently serving on the Board are independent within the meaning of Nasdaq Listing Rule 5605 with the exception of Nadir Ali and Wendy Loundermon, who are executive officers.

Committees of our Board

The Board has three standing committees:

the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee.

Audit Committee

The Audit Committee consists of Leonard Oppenheim, Tanveer Khader, and Kareem Irfan, all of whom are “independent” as defined under section 5605(a)(2) of the Nasdaq Listing Rules.

Oppenheim is the Chairman of the Audit Committee.

the Board has determined that Leonard Oppenheim qualifies as an “audit committee financial expert”

as defined in the

rules of the SEC.

The Audit Committee operates pursuant to a charter, which can be viewed on our website at http://www.inpixon.com

(under “Investors”).

In addition, the Board has determined that Leonard Oppenheim qualifies as an “audit committee financial expert” as defined in the rules of the SEC.

The Audit Committee operates pursuant to a charter, which can be viewed on our website at http://www.inpixon.com (under “Investors”).

The Audit Committee met 4 times during 2020.

All members attended more than 75% of such committee

All members attended more than 75% of such committee meetings.

The role of the Audit Committee is to:

oversee management’s

preparation of our financial statements and management’s conduct of the accounting and financial reporting processes;

oversee management’s

maintenance of internal controls and procedures for financial reporting;

oversee our compliance

with applicable legal and regulatory requirements, including without limitation, those requirements relating to financial

controls and reporting;

oversee the independent

auditor’s qualifications and independence;

oversee the performance

of the independent auditors, including the annual independent audit of our financial statements;

prepare the report

required by the rules of the SEC to be included in our Proxy Statement;

discharge such duties

and responsibilities as may be required of the Committee by the provisions of applicable law, rule or regulation.

Compensation Committee consists of Kareem Irfan, Leonard Oppenheim and Tanveer Khader, all of whom are “independent”

as defined in section 5605(a)(2) of the Nasdaq Listing Rules.

• oversee management’s preparation of our financial statements and management’s conduct of the accounting and financial reporting processes;

• oversee management’s maintenance of internal controls and procedures for financial reporting;

• oversee our compliance with applicable legal and regulatory requirements, including without limitation, those requirements relating to financial controls and reporting;

• oversee the independent auditor’s qualifications and independence;

• oversee the performance of the independent auditors, including the annual independent audit of our financial statements;

• prepare the report required by the rules of the SEC to be included in our Proxy Statement;

• discharge such duties and responsibilities as may be required of the Committee by the provisions of applicable law, rule or regulation.

Compensation Committee

The Compensation Committee consists of Kareem Irfan, Leonard Oppenheim and Tanveer Khader, all of whom are “independent” as defined in section 5605(a)(2) of the Nasdaq Listing Rules.

Irfan is the Chairman of the Compensation Committee.

The Compensation

Committee met 3 times during 2019.

The Compensation Committee met 2 times during 2020.

All members attended 75% or more of such committee meetings.

The role of the Compensation Committee

develop and recommend

to the independent directors of the Board the annual compensation (base salary, bonus, stock options and other benefits) for

our President/Chief Executive Officer;

review, approve

and recommend to the independent directors of the Board the annual compensation (base salary, bonus and other benefits) for

all of our Executive Officers (as used in Section 16 of the Securities Exchange Act of 1934 and defined in Rule 16a-1 thereunder);

review, approve

and recommend to the Board the aggregate number of equity grants to be granted to all other employees;

ensure that a significant

portion of executive compensation is reasonably related to the long-term interest of our stockholders.

copy of the charter of the Compensation Committee is available on our website at http://www.inpixon.com (under “Investors”).

Compensation Committee may form and delegate a subcommittee consisting of one or more members to perform the functions of the

Compensation Committee.

The Compensation Committee may engage outside advisers, including outside auditors, attorneys and consultants,

as it deems necessary to discharge its responsibilities.

The Compensation Committee has sole authority to retain and terminate

any compensation expert or consultant to be used to provide advice on compensation levels or assist in the evaluation of director,

President/Chief Executive Officer or senior executive compensation, including sole authority to approve the fees of any expert

or consultant and other retention terms.

In addition, the Compensation Committee considers, but is not bound by, the recommendations

of our Chief Executive Officer with respect to the compensation packages of our other executive officers.

and Corporate Governance Committee

The Nominating and

Corporate Governance Committee, or the “Governance Committee,”

consists of Tanveer Khader, Leonard Oppenheim and Kareem

Irfan, all of whom are “independent”

as defined in section 5605(a)(2) of the Nasdaq Listing Rules.

Khader is the

Chairman of the Governance Committee.

The Nominating and Corporate Governance Committee met 1 time during 2019.

All members attended

The role of the Compensation Committee is to:

• develop and recommend to the independent directors of the Board the annual compensation (base salary, bonus, stock options and other benefits) for our President/Chief Executive Officer;

• review, approve and recommend to the independent directors of the Board the annual compensation (base salary, bonus and other benefits) for all of our Executive Officers (as used in Section 16 of the Securities Exchange Act of 1934 and defined in Rule 16a-1 thereunder);

• review, approve and recommend to the Board the aggregate number of equity grants to be granted to all other employees;

• ensure that a significant portion of executive compensation is reasonably related to the long-term interest of our stockholders.

A copy of the charter of the Compensation Committee is available on our website at http://www.inpixon.com (under “Investors”).

The Compensation Committee may form and delegate a subcommittee consisting of one or more members to perform the functions of the Compensation Committee.

The Compensation Committee may engage outside advisers, including outside auditors, attorneys and consultants, as it deems necessary to discharge its responsibilities.

The Compensation Committee has sole authority to retain and terminate any compensation expert or consultant to be used to provide advice on compensation levels or assist in the evaluation of director, President/Chief Executive Officer or senior executive compensation, including sole authority to approve the fees of any expert or consultant and other retention terms.

In addition, the Compensation Committee considers, but is not bound by, the recommendations of our Chief Executive Officer with respect to the compensation packages of our other executive officers.

Nominating and Corporate Governance Committee

The Nominating and Corporate Governance Committee, or the “Governance Committee,” consists of Tanveer Khader, Leonard Oppenheim and Kareem Irfan, all of whom are “independent” as defined in section 5605(a)(2) of the Nasdaq Listing Rules.

Khader is the Chairman of the Governance Committee.

The Nominating and Corporate Governance Committee did not meet in person during 2020 and acted by written consent one time during 2020.

The role of the Governance Committee is to:

evaluate from time

to time the appropriate size (number of members) of the Board and recommend any increase or decrease;

determine the desired

skills and attributes of members of the Board, taking into account the needs of the business and listing standards;

establish criteria

for prospective members, conduct candidate searches, interview prospective candidates, and oversee programs to introduce the

candidate to us, our management, and operations;

annually recommend

to the Board persons to be nominated for election as directors;

recommend to the

Board the members of all standing Committees;

periodically review

the “independence”

of each director;

adopt or develop

for Board consideration corporate governance principles and policies;

provide oversight

to the strategic planning process conducted annually by our management.

A copy of the charter

of the Governance Committee is available on our website at http://www.inpixon.com (under “Investors”).

Communications

may communicate with the members of the Board, either individually or collectively, by writing to the Board at 2479 E.

Road, Suite 195, Palo Alto, CA 94303.

These communications will be reviewed by the Secretary as agent for the non-employee directors

in facilitating direct communication to the Board.

The Secretary will treat communications containing complaints relating to accounting,

internal accounting controls, or auditing matters as reports under our Whistleblower Policy.

Further, the Secretary will disregard

communications that are bulk mail, solicitations to purchase products or services not directly related either to us or the non-employee

directors’

roles as members of the Board, sent other than by stockholders in their capacities as such or from particular

authors or regarding particular subjects that the non-employee directors may specify from time to time, and all other communications

which do not meet the applicable requirements or criteria described below, consistent with the instructions of the non-employee

Communications.

The Secretary will summarize all stockholder communications directly relating to our business operations, the

Board, our officers, our activities or other matters and opportunities closely related to us.

This summary and copies of the actual

stockholder communications will then be circulated to the Chairman of the Governance Committee.

Proposals and Director Nominations and Recommendations.

Stockholder proposals are reviewed by the Secretary for compliance with

the requirements for such proposals set forth in our Bylaws and in Regulation 14a-8 promulgated under the Exchange Act.

proposals that meet these requirements will be summarized by the Secretary.

Summaries and copies of the stockholder proposals

are circulated to the Chairman of the Governance Committee.

nominations for directors are reviewed by the Secretary for compliance with the requirements for director nominations that are

set forth in our Bylaws.

• evaluate from time to time the appropriate size (number of members) of the Board and recommend any increase or decrease;

• determine the desired skills and attributes of members of the Board, taking into account the needs of the business and listing standards;

• establish criteria for prospective members, conduct candidate searches, interview prospective candidates, and oversee programs to introduce the candidate to us, our management, and operations;

• annually recommend to the Board persons to be nominated for election as directors;

• recommend to the Board the members of all standing Committees;

• periodically review the “independence” of each director;

• adopt or develop for Board consideration corporate governance principles and policies;

• provide oversight to the strategic planning process conducted annually by our management.

A copy of the charter of the Governance Committee is available on our website at http://www.inpixon.com (under “Investors”).

Stockholder Communications

Stockholders may communicate with the members of the Board, either individually or collectively, by writing to the Board at 2479 E.

Bayshore Road, Suite 195, Palo Alto, CA 94303.

These communications will be reviewed by the Secretary as agent for the non-employee directors in facilitating direct communication to the Board.

The Secretary will treat communications containing complaints relating to accounting, internal accounting controls, or auditing matters as reports under our Whistleblower Policy.

Further, the Secretary will disregard communications that are bulk mail, solicitations to purchase products or services not directly related either to us or the non-employee directors’ roles as members of the Board, sent other than by stockholders in their capacities as such or from particular authors or regarding particular subjects that the non-employee directors may specify from time to time, and all other communications which do not meet the applicable requirements or criteria described below, consistent with the instructions of the non-employee directors.

General Communications.

The Secretary will summarize all stockholder communications directly relating to our business operations, the Board, our officers, our activities or other matters and opportunities closely related to us.

This summary and copies of the actual stockholder communications will then be circulated to the Chairman of the Governance Committee.

Stockholder Proposals and Director Nominations and Recommendations.

Stockholder proposals are reviewed by the Secretary for compliance with the requirements for such proposals set forth in our Bylaws and in Regulation 14a-8 promulgated under the Exchange Act.

Stockholder proposals that meet these requirements will be summarized by the Secretary.

Summaries and copies of the stockholder proposals are circulated to the Chairman of the Governance Committee.

Stockholder nominations for directors are reviewed by the Secretary for compliance with the requirements for director nominations that are set forth in our Bylaws.

Stockholder nominations for directors that meet these requirements are summarized by the Secretary.

and copies of the nominations or recommendations are then circulated to the Chairman of the Governance Committee.

Governance Committee will consider director candidates recommended by stockholders.

If a director candidate is recommended by

a stockholder, the Governance Committee expects to evaluate such candidate in the same manner it evaluates director candidates

it identifies.

Stockholders desiring to make a recommendation to the Governance Committee should follow the procedures set forth

above regarding stockholder nominations for directors.

of Stockholder Communications.

Any stockholder communications which are not circulated to the Chairman of the Governance Committee

because they do not meet the applicable requirements or criteria described above will be retained by the Secretary for at least

ninety calendar days from the date on which they are received, so that these communications may be reviewed by the directors generally

if such information relates to the Board as a whole, or by any individual to whom the communication was addressed, should any

director elect to do so.

of Stockholder Communications.

Except as otherwise required by law or upon the request of a non-employee director, the Chairman

of the Governance Committee will determine when and whether a stockholder communication should be circulated among one or more

members of the Board and/or Company management.

Qualifications and Diversity

Board seeks independent directors who represent a diversity of backgrounds and experiences that will enhance the quality of the

Board’s deliberations and decisions.

Candidates should have substantial experience with one or more publicly traded companies

or should have achieved a high level of distinction in their chosen fields.

The Board is particularly interested in maintaining

a mix that includes individuals who are active or retired executive officers and senior executives, particularly those with experience

in technology;

Summaries and copies of the nominations or recommendations are then circulated to the Chairman of the Governance Committee.

The Governance Committee will consider director candidates recommended by stockholders.

If a director candidate is recommended by a stockholder, the Governance Committee expects to evaluate such candidate in the same manner it evaluates director candidates it identifies.

Stockholders desiring to make a recommendation to the Governance Committee should follow the procedures set forth above regarding stockholder nominations for directors.

Retention of Stockholder Communications.

Any stockholder communications which are not circulated to the Chairman of the Governance Committee because they do not meet the applicable requirements or criteria described above will be retained by the Secretary for at least ninety calendar days from the date on which they are received, so that these communications may be reviewed by the directors generally if such information relates to the Board as a whole, or by any individual to whom the communication was addressed, should any director elect to do so.

Distribution of Stockholder Communications.

Except as otherwise required by law or upon the request of a non-employee director, the Chairman of the Governance Committee will determine when and whether a stockholder communication should be circulated among one or more members of the Board and/or Company management.

Director Qualifications and Diversity

The Board seeks independent directors who represent a diversity of backgrounds and experiences that will enhance the quality of the Board’s deliberations and decisions.

Candidates should have substantial experience with one or more publicly traded companies or should have achieved a high level of distinction in their chosen fields.

The Board is particularly interested in maintaining a mix that includes individuals who are active or retired executive officers and senior executives, particularly those with experience in technology;

research and development;

1 unchanged sentence

or marketing and sales.

is no difference in the manner in which the Governance Committee evaluates nominees for director based on whether the nominee

is recommended by a stockholder.

In evaluating nominations to the Board, the Governance Committee also looks for depth and breadth

of experience within the Company’s industry and otherwise, outside time commitments, special areas of expertise, accounting

and finance knowledge, business judgment, leadership ability, experience in developing and assessing business strategies, corporate

governance expertise, and for incumbent members of the Board, the past performance of the incumbent director.

Each of the candidates

nominated for election to our Board at our last annual meeting of stockholders was recommended by the Governance Committee.

of Business Conduct and Ethics

Board has adopted a code of business conduct and ethics (the “Code”) designed, in part, to deter wrongdoing and to

promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal

and professional relationships, full, fair, accurate, timely and understandable disclosure in reports and documents that the Company

files with or submits to the SEC and in the Company’s other public communications, compliance with applicable governmental

laws, rules and regulations, the prompt internal reporting of Code violations to an appropriate person or persons, as identified

in the Code and accountability for adherence to the Code.

The Code applies to all directors, executive officers and employees

of the Company.

There is no difference in the manner in which the Governance Committee evaluates nominees for director based on whether the nominee is recommended by a stockholder.

In evaluating nominations to the Board, the Governance Committee also looks for depth and breadth of experience within the Company’s industry and otherwise, outside time commitments, special areas of expertise, accounting and finance knowledge, business judgment, leadership ability, experience in developing and assessing business strategies, corporate governance expertise, and for incumbent members of the Board, the past performance of the incumbent director.

Each of the candidates nominated for election to our Board at our last annual meeting of stockholders was recommended by the Governance Committee.

Code of Business Conduct and Ethics

The Board has adopted a code of business conduct and ethics (the “Code”) designed, in part, to deter wrongdoing and to promote honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships, full, fair, accurate, timely and understandable disclosure in reports and documents that the Company files with or submits to the SEC and in the Company’s other public communications, compliance with applicable governmental laws, rules and regulations, the prompt internal reporting of Code violations to an appropriate person or persons, as identified in the Code and accountability for adherence to the Code.

The Code applies to all directors, executive officers and employees of the Company.

The Code is periodically reviewed by the Board.

In the event we determine to amend or waive certain provisions

of the Code, we intend to disclose such amendments or waivers on our website at http://www.inpixon.com under the heading “Investors”

within four business days following such amendment or waiver or as otherwise required by the Nasdaq Listing Rules.

Board provides risk oversight for our entire company by receiving management presentations, including risk assessments, and discussing

these assessments with management.

The Board’s overall risk oversight, which focuses primarily on risks and exposures associated

with current matters that may present material risk to our operations, plans, prospects or reputation, is supplemented by the

various committees.

The Audit Committee discusses with management and our independent registered public accounting firm our risk

management guidelines and policies, our major financial risk exposures and the steps taken to monitor and control such exposures.

Our Compensation Committee oversees risks related to our compensation programs and discusses with management its annual assessment

of our employee compensation policies and programs.

Our Nomination and Governance Committee oversees risks related to corporate

governance and management and director succession planning.

Leadership Structure

The Chairman of

the Board presides at all meetings of the Board, unless such position is vacant, in which case, the Chief Executive Officer

of the Company presides.

The office of Chairman of the Board has been vacant since the resignation of Abdus Salam Qureishi

in September 2016.

Company has no fixed policy with respect to the separation of the offices of the Chairman of the Board and Chief Executive

The Board believes that the separation of the offices of the Chairman of the Board and Chief Executive Officer is in

the best interests of the Company and will review this determination from time to time.

In the event we determine to amend or waive certain provisions of the Code, we intend to disclose such amendments or waivers on our website at http://www.inpixon.com under the heading “Investors” within four business days following such amendment or waiver or as otherwise required by the Nasdaq Listing Rules.

Risk Oversight

Our Board provides risk oversight for our entire company by receiving management presentations, including risk assessments, and discussing these assessments with management.

The Board’s overall risk oversight, which focuses primarily on risks and exposures associated with current matters that may present material risk to our operations, plans, prospects or reputation, is supplemented by the various committees.

The Audit Committee discusses with management and our independent registered public accounting firm our risk management guidelines and policies, our major financial risk exposures and the steps taken to monitor and control such exposures.

Our Compensation Committee oversees risks related to our compensation programs and discusses with management its annual assessment of our employee compensation policies and programs.

Our Nomination and Governance Committee oversees risks related to corporate governance and management and director succession planning.

Board Leadership Structure

The Chairman of the Board presides at all meetings of the Board, unless such position is vacant, in which case, the Chief Executive Officer of the Company presides.

The office of Chairman of the Board has been vacant since the resignation of Abdus Salam Qureishi in September 2016.

The Company has no fixed policy with respect to the separation of the offices of the Chairman of the Board and Chief Executive Officer.

The Board believes that the separation of the offices of the Chairman of the Board and Chief Executive Officer is in the best interests of the Company and will review this determination from time to time.

EXECUTIVE COMPENSATION

table below sets forth, for the last two fiscal years, the compensation earned by (i) each individual who served as our principal

executive officer, (ii) our two other most highly compensated executive officers, other than our principal executive officer,

who were serving as an executive officer at the end of the last fiscal year, and (iii) up to two additional individuals for whom

disclosure would have been provided pursuant to the preceding paragraph (ii) but for the fact that the individual was not serving

as an executive officer of the Company at the end of the last completed fiscal year.

Together, these three individuals are sometimes

referred to as the “Named Executive Officers.”

Name and Principal Position

The table below sets forth, for the last two fiscal years, the compensation earned by (i) each individual who served as our principal executive officer and (ii) our two other most highly compensated executive officers, other than our principal executive officer, who were serving as an executive officer at the end of the last fiscal year.

Together, these individuals are sometimes referred to as the “Named Executive Officers.”

Name and Principal Position Year Salary

($) Option Awards

($)(1) All Other Compensation

$ 323,926 (2)

Nadir Ali, 2020 $ 280,000 $ 175,000 $ 336,000 (1) $ 239,999 (2) $ 1,030,999

Chief Executive Officer 2019 $ 280,000 $ 150,000 $ 804,000 (1) $ 323,926 (3) $ 1,557,926

$ 225,295 (2)

Soumya Das 2020 $ 290,625 $ 48,950 $ 168,000 (1) $ 136,728 (4) $ 644,303

Chief Operating Officer;

2 unchanged sentences

Chief Financial Officer 2019 $ 250,000 $ 60,000 $ 562,800 (1) $ 17,021 (5) $ 889,821

fair value of employee option grants are estimated on the date of grant using the Black-Scholes option pricing model with

key weighted average assumptions, expected stock volatility and risk free interest rates based on US Treasury rates from the

applicable periods.

Accrued vacation paid as compensation, automobile

allowance and housing allowance.

Represents commission and automobile allowance.

(1) The fair value of employee option grants are estimated on the date of grant using the Black-Scholes option pricing model with key weighted average assumptions, expected stock volatility and risk free interest rates based on US Treasury rates from the applicable periods.

(2) Automobile allowance and housing allowance.

(3) Accrued vacation paid as compensation, automobile allowance and housing allowance.

(4) Commission and automobile allowance.

(5) Accrued vacation paid as compensation.

Equity Awards at Fiscal Year-End

than as set forth below, there were no outstanding unexercised options, unvested stock, and/or equity incentive plan awards issued

to our Named Executive Officers as of December 31, 2019.

unexercisable

Outstanding Equity Awards at Fiscal Year-End

Other than as set forth below, there were no outstanding unexercised options, unvested stock, and/or equity incentive plan awards issued to our Named Executive Officers as of December 31, 2020.

Option Awards Stock Awards

Name Grant Date Number of

exercisable Number of

unexercisable Equity

shares, units

Nadir Ali 12/21/2012 1 (1) 0 0 225,643.05 12/21/2022 0 0 0 0

08/14/2013 1 (1) 0 0 1,952,678.70 08/14/2023 0 0 0 0

04/17/2015 1 (2) 0 0 1,677,857.40 04/17/2025 0 0 0 0

05/17/2018 312 (1) 0 0 570.60 05/17/2028 0 0 0 0

01/25/2019 10186 (3) 926 (3) 0 101.70 01/25/2029 0 0 0 0

05/10/2019 7408 (3) 3704 (3) 0 33.75 05/10/2029 0 0 0 0

5/08/20202 333,333 (4) 666,667 (4) 0 1.10 05/08/2030 0 0 0 0

Soumya Das 02/03/2017 0 1 (2) 0 188,035.74 02/03/2027 0 0 0 0

05/17/2018 187 (1) 0 0 570.60 05/17/2028 0 0 0 0

01/25/2019 6112 (3) 555 (3) 0 101.70 01/25/2029 0 0 0 0

05/10/2019 4445 (3) 2222 (3) 0 33.75 05/10/2029 0 0 0 0

5/08/20202 166,666 (4) 333,334 (4) 0 1.10 05/08/2030 0 0 0 0

Wendy Loundermon 12/05/2011 1 (1) 0 0 1,012,500.00 12/05/2021 0 0 0 0

option is 100% vested.

This option vests

1/48 th per month at the end of each month starting on the grant date.

option vests 1/12 th per month at the end of each month starting on the grant date.

Agreements and Arrangements

July 1, 2010, Nadir Ali entered into an at-will Employment and Non-Compete Agreement, as subsequently amended, with Inpixon Federal,

Inc., Inpixon Government Services and Inpixon Consulting prior to their acquisition by the Company.

Under the terms of the Employment

Agreement Mr.

12/21/2012 1 (1) 0 0 225,643.05 12/21/2022 0 0 0 0

11/18/2013 1 (1) 0 0 1,851,428.70 11/18/2023 0 0 0 0

05/09/2014 1 (1) 0 0 3,507,589.35 05/09/2024 0 0 0 0

08/05/2015 1 (2) 0 0 1,265,625.00 08/05/2025 0 0 0 0

02/25/2016 0 1 (2) 0 376,071.30 02/25/2026 0 0 0 0

07/20/2016 0 1 (2) 0 339,910.65 07/20/2026 0 0 0 0

05/17/2018 218 (1) 0 0 570.60 05/17/2028 0 0 0 0

01/25/2019 7130 (3) 648 (3) 0 101.70 01/25/2029 0 0 0 0

05/10/2019 5186 (3) 2592 (3) 0 33.75 05/10/2029 0 0 0 0

5/08/20202 166,666 (4) 333,334 (4) 0 1.10 05/08/2030 0 0 0 0

(1) This option is 100% vested.

(2) This option vests 1/48 th per month at the end of each month starting on the grant date.

(3) This option vests 1/12 th per month at the end of each month starting on the grant date.

(4) This option vests 1/24th per month at the end of each month starting on the grant date.

Employment Agreements and Arrangements

On July 1, 2010, Nadir Ali entered into an at-will Employment and Non-Compete Agreement, as subsequently amended, with Inpixon Federal, Inc., Inpixon Government Services and Inpixon Consulting prior to their acquisition by the Company.

Under the terms of the Employment Agreement Mr.

Ali serves as President.

1 unchanged sentence

Ali became CEO in September 2011.

Ali’s salary under the agreement was initially $240,000 per annum plus other benefits including a bonus plan,

a housing allowance, health insurance, life insurance and other standard Inpixon employee benefits.

Ali’s employment

is terminated without Cause (as defined), he will receive his base salary for 12 months from the date of termination.

employment agreement provides that he will not compete with the Company and will be subject to non-solicitation provisions relating

to employees, consultants and customers, distributors, partners, joint ventures or suppliers of the Company during the term of

his employment or consulting relationship with the Company.

On April 17, 2015, the compensation committee approved the increase

Ali’s annual salary to $252,400, effective January 1, 2015.

Effective May 16, 2018 the compensation committee approved

an increase in Mr.

Ali’s annual salary to $280,000 and an auto allowance of $1,000 a month.

On November 4, 2016,

and effective as of November 7, 2016, Mr.

Ali’s salary under the agreement was initially $240,000 per annum plus other benefits including a bonus plan, a housing allowance, health insurance, life insurance and other standard Inpixon employee benefits.

Ali’s employment is terminated without Cause (as defined), he will receive his base salary for 12 months from the date of termination.

Ali’s employment agreement provides that he will not compete with the Company and will be subject to non-solicitation provisions relating to employees, consultants and customers, distributors, partners, joint ventures or suppliers of the Company during the term of his employment or consulting relationship with the Company.

On April 17, 2015, the compensation committee approved the increase of Mr.

Ali’s annual salary to $252,400, effective January 1, 2015.

Effective May 16, 2018 the compensation committee approved an increase in Mr.

Ali’s annual salary to $280,000 and an auto allowance of $1,000 a month.

On November 4, 2016, and effective as of November 7, 2016, Mr.

Das entered into an employment agreement to serve as Chief Marketing Officer of the Company.

1 unchanged sentence

In accordance with the terms of the agreement, Mr.

Das will receive

a base salary of $250,000 per annum.

Das will receive a base salary of $250,000 per annum.

In addition, Mr.

Das will receive a bonus up to $75,000 annually, provided that he completes

the required tasks before their deadlines, and the tasks, their deadlines and the amount of corresponding bonuses shall be determined

by the Company and the CEO.

The agreement was effective for an initial term of twenty-four (24) months and was automatically renewed

for one additional twelve (12) month period.

Das will receive a bonus up to $75,000 annually, provided that he completes the required tasks before their deadlines, and the tasks, their deadlines and the amount of corresponding bonuses shall be determined by the Company and the CEO.

The agreement was effective for an initial term of twenty-four (24) months and was automatically renewed for one additional twelve (12) month period.

The Company may terminate the services of Mr.

Das with or without “just cause,”

(as defined).

Das with or without “just cause,” (as defined).

If the Company terminates Mr.

employment without just cause, or if Mr.

Das resigns within twenty-four

(24) months following a change of control (as defined) and as a result of a material diminution of his position or compensation,

Das’ employment without just cause, or if Mr.

Das resigns within twenty-four (24) months following a change of control (as defined) and as a result of a material diminution of his position or compensation, Mr.

Das will receive (1) his base salary at the then current rate and levels for one (1) month if Mr.

Das has been employed by

the Company for at least six (6) months but not more than twelve (12) months as of the date of termination or resignation, for

three (3) months if Mr.

Das has been employed by the Company more than twelve (12) but not more than twenty-four (24) months as

of the date of termination or resignation, or for six (6) months if Mr.

Das has been employed by the Company for more than twenty-four

(24) months as of the date of resignation or termination;

Das has been employed by the Company for at least six (6) months but not more than twelve (12) months as of the date of termination or resignation, for three (3) months if Mr.

Das has been employed by the Company more than twelve (12) but not more than twenty-four (24) months as of the date of termination or resignation, or for six (6) months if Mr.

Das has been employed by the Company for more than twenty-four (24) months as of the date of resignation or termination;

(2) 50% of the value of any accrued but unpaid bonus that Mr.

Das otherwise

would have received;

Das otherwise would have received;

(3) the value of any accrued but unpaid vacation time;

and (4) any unreimbursed business expenses and travel

expenses that are reimbursable under the agreement.

and (4) any unreimbursed business expenses and travel expenses that are reimbursable under the agreement.

If the Company terminates Mr.

employment with just cause, Mr.

will receive only the portion of his base salary and accrued but unused vacation pay that has been earned through the date of termination.

Das’ employment with just cause, Mr.

Das will receive only the portion of his base salary and accrued but unused vacation pay that has been earned through the date of termination.

On August 31, 2018, the Company amended Mr.

employment agreement to make the following changes to his compensation effective

May 14, 2018:

(1) increase in base salary to $275,000 per year, (2) have up to $50,000 in MBO’s annually, (3) commissions

equal to 2% of recognized revenue associated with the IPA product line paid quarterly and subject to the Company policies in connection

with commissions payable and (4) provide a transportation allowance of $1,000 per month.

Das’ employment agreement to make the following changes to his compensation effective May 14, 2018:

(1) increase in base salary to $275,000 per year, (2) have up to $50,000 in MBO’s annually, (3) commissions equal to 2% of recognized revenue associated with the IPA product line paid quarterly and subject to the Company policies in connection with commissions payable and (4) provide a transportation allowance of $1,000 per month.

On May 10, 2019, the Company amended Mr.

commission plan to include a 1% commission on recognized revenue associated with the Shoom product line paid quarterly

and subject to Company commission plan policies.

October 21, 2014, and effective as of October 1, 2014, the Company entered into an at-will employment agreement with Wendy Loundermon.

Das’ commission plan to include a 1% commission on recognized revenue associated with the Shoom product line paid quarterly and subject to Company commission plan policies.

Effective as of March 2021, Mr.

Das resigned from his position as Chief Marketing Officer.

Wendy Loundermon

On October 21, 2014, and effective as of October 1, 2014, the Company entered into an at-will employment agreement with Wendy Loundermon.

Loundermon currently serves as CFO, Director and Secretary of the Company and Secretary of Inpixon Canada, Inc.

the agreement, Ms.

Loundermon was compensated at an annual rate of $200,000 and is entitled to benefits customarily provided to

senior management including equity awards and cash bonuses subject to the satisfaction of certain performance goals determined

by the Company.

Pursuant to the agreement, Ms.

Loundermon was compensated at an annual rate of $200,000 and is entitled to benefits customarily provided to senior management including equity awards and cash bonuses subject to the satisfaction of certain performance goals determined by the Company.

The standards and goals and the bonus targets is set by the compensation committee, in its sole discretion.

Company may terminate the services of Ms.

Loundermon with or without “cause”

(as defined).

If the Company terminates

Loundermon’s employment without cause or in connection with a change of control (as defined), Ms.

Loundermon will receive

(1) severance consisting of her base salary at the then current rate for twelve (12) months from the date of termination,

and (2) her accrued but unpaid salary.

Loundermon’s employment is terminated under any circumstances other than the

The Company may terminate the services of Ms.

Loundermon with or without “cause” (as defined).

If the Company terminates Ms.

Loundermon’s employment without cause or in connection with a change of control (as defined), Ms.

Loundermon will receive (1) severance consisting of her base salary at the then current rate for twelve (12) months from the date of termination, and (2) her accrued but unpaid salary.

Loundermon’s employment is terminated under any circumstances other than the above, Ms.

Loundermon will receive her accrued but unpaid salary.

Loundermon’s salary was increased to $228,500 effective

April 1, 2017 and to $250,000 effective March 1, 2018.

Stock Incentive Plans

Loundermon’s salary was increased to $228,500 effective April 1, 2017, $250,000 effective March 1, 2018 and $280,000 effective January 2021.

Employee Stock Incentive Plans

2018 Employee Stock Incentive Plan

following is a summary of the material terms of our 2018 Employee Stock Incentive Plan, as amended to date (the “2018 Plan”).

The following is a summary of the material terms of our 2018 Employee Stock Incentive Plan, as amended to date (the “2018 Plan”).

This description is not complete.

For more information, we refer you to the full text of the 2018 Plan.

2018 Plan is an important part of our compensation program.

It promotes financial saving for the future by our employees, fosters

good employee relations, and encourages employees to acquire shares of our common stock, thereby better aligning their interests

with those of the other stockholders.

Therefore, the Board believes it is essential to our ability to attract, retain, and motivate

highly qualified employees in an extremely competitive environment both in the United States and internationally.

of Shares of Common Stock.

The number of shares of our common stock initially reserved for issuance under the 2018 Plan was

2,000,000, which number is automatically increased on the first day of each quarter, beginning on April 1, 2018 and for each quarter

thereafter through October 1, 2028, by a number of shares of common stock equal to the least of (i) 1,500,000 shares, (ii) twenty

percent (20%) of the outstanding shares of common stock on the last day of the immediately preceding calendar quarter, or (iii)

such number of shares that may be determined by the Board.

The amount of shares available for issuance is not adjusted in connection

with a change in the outstanding shares of common stock by reason of stock dividends, stock splits, reverse stock splits, recapitalizations,

mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations;

that in no event will the Company issue more than 63,000,000 shares of common stock under the 2018 Plan, including the maximum

amount of shares of common stock that may be added to the 2018 Plan in accordance with the automatic quarterly increases.

The 2018 Plan provides for the granting of incentive stock options, non-qualified stock options

(“NQSOs”), stock grants and other stock-based awards, including Restricted Stock and Restricted Stock Units (as

defined in the 2018 Plan).

Incentive and Nonqualified

Stock Options.

The 2018 Plan is an important part of our compensation program.

It promotes financial saving for the future by our employees, fosters good employee relations, and encourages employees to acquire shares of our common stock, thereby better aligning their interests with those of the other stockholders.

Therefore, the Board believes it is essential to our ability to attract, retain, and motivate highly qualified employees in an extremely competitive environment both in the United States and internationally.

Amount of Shares of Common Stock.

The number of shares of our common stock initially reserved for issuance under the 2018 Plan was 2,000,000, which number is automatically increased on the first day of each quarter, beginning on April 1, 2018 and for each quarter thereafter through October 1, 2028, by a number of shares of common stock equal to the least of (i) 1,500,000 shares, (ii) twenty percent (20%) of the outstanding shares of common stock on the last day of the immediately

preceding calendar quarter, or (iii) such number of shares that may be determined by the Board.

The amount of shares available for issuance is not adjusted in connection with a change in the outstanding shares of common stock by reason of stock dividends, stock splits, reverse stock splits, recapitalizations, mergers, consolidations, combinations or exchanges of shares, separations, reorganizations or liquidations;

however, that in no event will the Company issue more than 63,000,000 shares of common stock under the 2018 Plan, including the maximum amount of shares of common stock that may be added to the 2018 Plan in accordance with the automatic quarterly increases.

Types of Awards .

The 2018 Plan provides for the granting of incentive stock options, non-qualified stock options (“NQSOs”), stock grants and other stock-based awards, including Restricted Stock and Restricted Stock Units (as defined in the 2018 Plan).

• Incentive and Nonqualified Stock Options.

The plan administrator determines the exercise price of each stock option.

The exercise price of an NQSO may

not be less than the fair market value of our common stock on the date of grant.

The exercise price of an incentive stock

option may not be less than the fair market value of our common stock on the date of grant if the recipient holds 10% or less

of the combined voting power of our securities, or 110% of the fair market value of a share of our common stock on the date

of grant otherwise.

The exercise price of an NQSO may not be less than the fair market value of our common stock on the date of grant.

The exercise price of an incentive stock option may not be less than the fair market value of our common stock on the date of grant if the recipient holds 10% or less of the combined voting power of our securities, or 110% of the fair market value of a share of our common stock on the date of grant otherwise.

• Stock Grants.

plan administrator may grant or sell stock, including restricted stock, to any participant, which purchase price, if any,

may not be less than the par value of shares of our common stock.

The stock grant will be subject to the conditions and restrictions

determined by the administrator.

The recipient of a stock grant shall have the rights of a stockholder with respect to the

shares of stock issued to the holder under the 2018 Plan.

The plan administrator may grant or sell stock, including restricted stock, to any participant, which purchase price, if any, may not be less than the par value of shares of our common stock.

The stock grant will be subject to the conditions and restrictions determined by the administrator.

The recipient of a stock grant shall have the rights of a stockholder with respect to the shares of stock issued to the holder under the 2018 Plan.

• Stock-Based Awards.

The plan administrator of the 2018 Plan may grant other stock-based awards, including stock appreciation rights, restricted

stock and restricted stock units, with terms approved by the administrator, including restrictions related to the awards.

The holder of a stock-based award shall not have the rights of a stockholder except to the extent permitted in the applicable

Administration .&emsp;Our Board is the administrator of the 2018 Plan, except to the extent it delegates its authority to a

committee, in which case the committee shall be the administrator.

Our Board has delegated this authority to our compensation

The administrator has the authority to determine the terms of awards, including exercise and purchase price, the number

of shares subject to awards, the value of our common stock, the vesting schedule applicable to awards, the form of consideration,

if any, payable upon exercise or settlement of an award and the terms of award agreements for use under the 2018 Plan.

Eligibility .&emsp;The

plan administrator will determine the participants in the 2018 Plan from among our employees, directors and consultants.

may be approved in advance with the effectiveness of the grant contingent and effective upon such person’s commencement

of service within a specified period.

of Service .&emsp;Unless otherwise provided by the administrator or in an award agreement, upon a termination of a participant’s

service, all unvested options then held by the participant will terminate and all other unvested awards will be forfeited.

Transferability .&emsp;Awards

under the 2018 Plan may not be transferred except by will or by the laws of descent and distribution, unless otherwise provided

by the plan administrator in its discretion and set forth in the applicable agreement, provided that no award may be transferred

Adjustment .&emsp;In

the event of a stock dividend, stock split, recapitalization or reorganization or other change in change in capital structure,

the plan administrator will make appropriate adjustments to the number and kind of shares of stock or securities subject to awards.

Transaction .&emsp;If we are acquired, the plan administrator will:

(i) arrange for the surviving entity or acquiring entity

(or the surviving or acquiring entity’s parent company) to assume or continue the award or to substitute a similar award

for the award;

(ii) cancel or arrange for cancellation of the award, to the extent not vested or not exercised prior to the effective

time of the transaction, in exchange for such cash consideration, if any, as the plan administrator in its sole discretion, may

consider appropriate;

or (iii) make a payment, in such form as may be determined by the plan administrator equal to the excess,

if any, of (A) the value of the property the holder would have received upon the exercise of the award immediately prior to the

effective time of the transaction, over (B) any exercise price payable by such holder in connection with such exercise.

in connection with such transaction, the plan administrator may accelerate the vesting, in whole or in part, of the award (and,

if applicable, the time at which the award may be exercised) to a date prior to the effective time of such transaction and may

arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to an award.

and Termination .&emsp;The 2018 Plan will terminate on January 4, 2028 or at an earlier date by vote of our Board;

however, that any such earlier termination shall not affect any awards granted under the 2018 Plan prior to the date of such termination.

The 2018 Plan may be amended by our Board, except that our Board may not alter the terms of the 2018 Plan if it would adversely

affect a participant’s rights under an outstanding stock right without the participant’s consent.

Board may at any time amend or terminate the 2018 Plan;

provided that no amendment may be made without the approval of the stockholder

if such amendment would increase either the maximum number of shares which may be granted under the 2018 Plan or any specified

limit on any particular type or types of award, or change the class of employees to whom an award may be granted, or withdraw

the authority to administer the 2018 Plan from a committee whose members satisfy the independence and other requirements of Section

162(m) and applicable SEC and Nasdaq requirements.

Pursuant to the listing standards of the Nasdaq Stock Market, certain other

material revisions to the 2018 Plan may also require stockholder approval.

Income Tax Consequences of the 2018 Plan.

The federal income tax consequences of grants under the 2018 Plan will depend on

the type of grant.

The following is a general summary of the principal United States federal income taxation consequences to participants

and us under current law with respect to participation in the 2018 Plan.

This summary is not intended to be exhaustive and does

not discuss the income tax laws of any city, state or foreign jurisdiction in which a participant may reside or the rules applicable

to deferred compensation under Section 409A of the Code.

Our ability to realize the benefit of any tax deductions described below

depends on our generation of taxable income as well as the requirement of reasonableness, the provisions of Section 162(m) of

the Code and the satisfaction of our tax reporting obligations.

the grantees’

standpoint, as a general rule, ordinary income will be recognized at the time of delivery of shares of our

common stock or payment of cash under the 2018 Plan.

Future appreciation on shares of our common stock held beyond the ordinary

income recognition event will be taxable as capital gain when the shares of our common stock are sold.

The tax rate applicable

to capital gain will depend upon how long the grantee holds the shares.

We, as a general rule, will be entitled to a tax deduction

that corresponds in time and amount to the ordinary income recognized by the grantee, and we will not be entitled to any tax deduction

with respect to capital gain income recognized by the grantee.

to these general rules arise under the following circumstances:

If shares of our

common stock, when delivered, are subject to a substantial risk of forfeiture by reason of any employment or performance-related

condition, ordinary income taxation and our tax deduction will be delayed until the risk of forfeiture lapses, unless the

grantee makes a special election to accelerate taxation under section 83(b) of the Code.

If an employee exercises

a stock option that qualifies as an ISO, no ordinary income will be recognized, and we will not be entitled to any tax deduction,

if shares of our common stock acquired upon exercise of the stock option are held until the later of (A) one year from the

date of exercise and (B) two years from the date of grant.

However, if the employee disposes of the shares acquired upon exercise

of an ISO before satisfying both holding period requirements, the employee will recognize ordinary income at the time of the

disposition equal to the difference between the fair market value of the shares on the date of exercise (or the amount realized

on the disposition, if less) and the exercise price, and we will be entitled to a tax deduction in that amount.

if any, in excess of the amount recognized as ordinary income will be long-term or short-term capital gain, depending upon

the length of time the employee held the shares before the disposition.

A grant may be subject

to a 20% tax, in addition to ordinary income tax, at the time the grant becomes vested, plus interest, if the grant constitutes

deferred compensation under section 409A of the Code and the requirements of section 409A of the Code are not satisfied.

162(m) of the Code generally disallows a publicly held corporation’s tax deduction for compensation paid to its chief executive

officer or certain other officers in excess of $1 million in any year.

Qualified performance-based compensation is excluded from

the $1 million deductibility limit, and therefore remains fully deductible by the corporation that pays it.

We intend that options

and SARs granted under the 2018 Plan will be qualified performance-based compensation.

Stock units, stock awards, dividend equivalents,

and other stock-based awards granted under the 2018 Plan may be designated as qualified performance-based compensation if the

Committee conditions such grants on the achievement of specific performance goals in accordance with the requirements of section

162(m) of the Code.

have the right to require that grantees pay to us an amount necessary for us to satisfy our federal, state or local tax withholding

obligations with respect to grants.

We may withhold from other amounts payable to a grantee an amount necessary to satisfy these

The Committee may permit a grantee to satisfy our withholding obligation with respect to grants paid in shares of

our common stock by having shares withheld, at the time the grants become taxable, provided that the number of shares withheld

does not exceed the individual’s minimum applicable withholding tax rate for federal, state and local tax liabilities.

The plan administrator of the 2018 Plan may grant other stock-based awards, including stock appreciation rights, restricted stock and restricted stock units, with terms approved by the administrator, including restrictions related to the awards.

The holder of a stock-based award shall not have the rights of a stockholder except to the extent permitted in the applicable agreement.

Plan Administration .Our Board is the administrator of the 2018 Plan, except to the extent it delegates its authority to a committee, in which case the committee shall be the administrator.

Our Board has delegated this authority to our compensation committee.

The administrator has the authority to determine the terms of awards, including exercise and purchase price, the number of shares subject to awards, the value of our common stock, the vesting schedule applicable to awards, the form of consideration, if any, payable upon exercise or settlement of an award and the terms of award agreements for use under the 2018 Plan.

Eligibility .The plan administrator will determine the participants in the 2018 Plan from among our employees, directors and consultants.

A grant may be approved in advance with the effectiveness of the grant contingent and effective upon such person’s commencement of service within a specified period.

Termination of Service .Unless otherwise provided by the administrator or in an award agreement, upon a termination of a participant’s service, all unvested options then held by the participant will terminate and all other unvested awards will be forfeited.

Transferability .Awards under the 2018 Plan may not be transferred except by will or by the laws of descent and distribution, unless otherwise provided by the plan administrator in its discretion and set forth in the applicable agreement, provided that no award may be transferred for value.

Adjustment .In the event of a stock dividend, stock split, recapitalization or reorganization or other change in change in capital structure, the plan administrator will make appropriate adjustments to the number and kind of shares of stock or securities subject to awards.

Corporate Transaction .If we are acquired, the plan administrator will:

(i) arrange for the surviving entity or acquiring entity (or the surviving or acquiring entity’s parent company) to assume or continue the award or to substitute a similar award for the award;

(ii) cancel or arrange for cancellation of the award, to the extent not vested or not exercised prior to the effective time of the transaction, in exchange for such cash consideration, if any, as the plan administrator in its sole discretion, may consider appropriate;

or (iii) make a payment, in such form as may be determined by the plan administrator equal to the excess, if any, of (A) the value of the property the holder would have received upon the exercise of the award immediately prior to the effective time of the transaction, over (B) any exercise price payable by such holder in connection with such exercise.

In addition in connection with such transaction, the plan administrator may accelerate the vesting, in whole or in part, of the award

(and, if applicable, the time at which the award may be exercised) to a date prior to the effective time of such transaction and may arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us with respect to an award.

Amendment and Termination .The 2018 Plan will terminate on January 4, 2028 or at an earlier date by vote of our Board;

provided, however, that any such earlier termination shall not affect any awards granted under the 2018 Plan prior to the date of such termination.

The 2018 Plan may be amended by our Board, except that our Board may not alter the terms of the 2018 Plan if it would adversely affect a participant’s rights under an outstanding stock right without the participant’s consent.

The Board may at any time amend or terminate the 2018 Plan;

provided that no amendment may be made without the approval of the stockholder if such amendment would increase either the maximum number of shares which may be granted under the 2018 Plan or any specified limit on any particular type or types of award, or change the class of employees to whom an award may be granted, or withdraw the authority to administer the 2018 Plan from a committee whose members satisfy the independence and other requirements of Section 162(m) and applicable SEC and Nasdaq requirements.

Pursuant to the listing standards of the Nasdaq Stock Market, certain other material revisions to the 2018 Plan may also require stockholder approval.

Federal Income Tax Consequences of the 2018 Plan.

The federal income tax consequences of grants under the 2018 Plan will depend on the type of grant.

The following is a general summary of the principal United States federal income taxation consequences to participants and us under current law with respect to participation in the 2018 Plan.

This summary is not intended to be exhaustive and does not discuss the income tax laws of any city, state or foreign jurisdiction in which a participant may reside or the rules applicable to deferred compensation under Section 409A of the Code.

Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of our tax reporting obligations.

From the grantees’ standpoint, as a general rule, ordinary income will be recognized at the time of delivery of shares of our common stock or payment of cash under the 2018 Plan.

Future appreciation on shares of our common stock held beyond the ordinary income recognition event will be taxable as capital gain when the shares of our common stock are sold.

The tax rate applicable to capital gain will depend upon how long the grantee holds the shares.

We, as a general rule, will be entitled to a tax deduction that corresponds in time and amount to the ordinary income recognized by the grantee, and we will not be entitled to any tax deduction with respect to capital gain income recognized by the grantee.

Exceptions to these general rules arise under the following circumstances:

• If shares of our common stock, when delivered, are subject to a substantial risk of forfeiture by reason of any employment or performance-related condition, ordinary income taxation and our tax deduction will be delayed until the risk of forfeiture lapses, unless the grantee makes a special election to accelerate taxation under section 83(b) of the Code.

• If an employee exercises a stock option that qualifies as an ISO, no ordinary income will be recognized, and we will not be entitled to any tax deduction, if shares of our common stock acquired upon exercise of the stock option are held until the later of (A) one year from the date of exercise and (B) two years from the date of grant.

However, if the employee disposes of the shares acquired upon exercise of an ISO before satisfying both holding period requirements, the employee will recognize ordinary income at the time of the disposition equal to the difference between the fair market value of the shares on the date of exercise (or the amount realized on the disposition, if less) and the exercise price, and we will be entitled to a tax deduction in that amount.

The gain, if any, in excess of the amount recognized as ordinary income will be long-term or short-term capital gain, depending upon the length of time the employee held the shares before the disposition.

• A grant may be subject to a 20% tax, in addition to ordinary income tax, at the time the grant becomes vested, plus interest, if the grant constitutes deferred compensation under section 409A of the Code and the requirements of section 409A of the Code are not satisfied.

Section 162(m) of the Code generally disallows a publicly held corporation’s tax deduction for compensation paid to its chief executive officer or certain other officers in excess of $1 million in any year.

Qualified performance-based compensation is excluded from the $1 million deductibility limit, and therefore remains fully deductible by the corporation that pays it.

We intend that options and SARs granted under the 2018 Plan will be qualified performance-based compensation.

Stock units, stock awards, dividend equivalents, and other stock-based awards granted under the 2018 Plan may be designated as qualified performance-based compensation if the Committee conditions such grants on the achievement of specific performance goals in accordance with the requirements of section 162(m) of the Code.

We have the right to require that grantees pay to us an amount necessary for us to satisfy our federal, state or local tax withholding obligations with respect to grants.

We may withhold from other amounts payable to a grantee an amount necessary to satisfy these obligations.

The Committee may permit a grantee to satisfy our withholding obligation with respect to grants paid in shares of our common stock by having shares withheld, at the time the grants become taxable, provided that the number of shares withheld does not exceed the individual’s minimum applicable withholding tax rate for federal, state and local tax liabilities.

2011 Employee Stock Incentive Plan

as set forth below, the material terms of our 2011 Employee Stock Incentive Plan, as amended to date (the “2011 Plan”)

are substantially similar to the material terms of the 2018 Plan.

Except as set forth below, the material terms of our 2011 Employee Stock Incentive Plan, as amended to date (the “2011 Plan”) are substantially similar to the material terms of the 2018 Plan.

However, this description is not complete.

For more information,

we refer you to the full text of the 2011 Plan.

2011 Plan is intended to encourage ownership of common stock by our employees and directors and certain of our consultants in

order to attract and retain such people, to induce them to work for the benefit of us and to provide additional incentive for

them to promote our success.

The number of shares of our common stock available for issuance under the 2011 Plan is 158,424 as

of December 31, 2019, which number is automatically increased on January 1 of each of year by 10% of the aggregate number of shares

of common stock issued by the Company in the prior calendar year.

Authorized for Issuance under Equity Compensation Plans

following table provides information as of December 31, 2019 regarding the shares of our common stock to be issued upon exercise

of outstanding options or available for issuance under equity compensation plans and other compensation arrangements that were

(i) adopted by our security holders and (ii) were not approved by our security holders.

Plan Category

of securities to be issued upon

For more information, we refer you to the full text of the 2011 Plan.

The 2011 Plan is intended to encourage ownership of common stock by our employees and directors and certain of our consultants in order to attract and retain such people, to induce them to work for the benefit of us and to provide additional incentive for them to promote our success.

The number of shares of our common stock available for issuance under the 2011 Plan is 158,424 as of December 31, 2019, which number is automatically increased on January 1 of each of year by 10% of the aggregate number of shares of common stock issued by the Company in the prior calendar year.

Securities Authorized for Issuance under Equity Compensation Plans

The following table provides information as of December 31, 2020 regarding the shares of our common stock to be issued upon exercise of outstanding options or available for issuance under equity compensation plans and other compensation arrangements that were (i) adopted by our security holders and (ii) were not approved by our security holders.

Plan Category Number of securities to be issued upon

exercise of outstanding options

Weighted-average

(a) Weighted-average exercise

price of outstanding

of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column

Equity compensation plans approved by security

8,198,309 (2)

Equity compensation plans not

approved by security holders

$ 1,952,678.70

Represents 5 shares

of common stock that may be issued pursuant to outstanding stock options granted under the 2011 Plan and 121,583 shares of

common stock that may be issued pursuant to outstanding stock options granted under the 2018 Plan.

Represents 3,516

shares of common stock available for future issuance in connection with equity award grants under the 2011 Plan and 8,194,793

shares of common stock available for future issuance in connection with equity award grants under the 2018 Plan.

Represents shares

of common stock issuable upon the exercise of stock options granted to Nadir Ali on August 14, 2013 outside of the 2011 Plan

and the 2018 Plan.

following table provides certain summary information concerning compensation awarded to, earned by or paid to our Directors in

the year ended December 31, 2019 except Nadir Ali and Wendy Loundermon, whose aggregate compensation information has been disclosed

Earned or paid in cash

Incentive plan compensation

deferred compensation earnings

other compensation

(b) Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column a)

Equity compensation plans approved by security holders 5,450,056 (1) $ 23.41 9,197,287 (2)

Equity compensation plans not approved by security holders 1 (3) $ 1,952,678.70 —

Total 5,450,057 $ 23.76 9,197,287

(1) Represents 89 shares of common stock that may be issued pursuant to outstanding stock options granted under the 2011 Plan and 5,449,967 shares of common stock that may be issued pursuant to outstanding stock options granted under the 2018 Plan.

(2) Represents 417,181 shares of common stock available for future issuance in connection with equity award grants under the 2011 Plan and 8,780,106 shares of common stock available for future issuance in connection with equity award grants under the 2018 Plan.

(3) Represents shares of common stock issuable upon the exercise of stock options granted to Nadir Ali on August 14, 2013 outside of the 2011 Plan and the 2018 Plan.

Director Compensation

The following table provides certain summary information concerning compensation awarded to, earned by or paid to our Directors in the year ended December 31, 2020 except Nadir Ali and Wendy Loundermon, whose aggregate compensation information has been disclosed above.

Name Fees Earned or paid in cash

($) Option awards

($) Non-equity Incentive plan compensation

($) Nonqualified deferred compensation earnings

($) All other compensation

Leonard Oppenheim $ 56,000 — $ 6,720 — — $ — $ 62,720

Kareem Irfan $ 53,000 — $ 6,720 — — $ — $ 59,720

Tanveer Khader $ 47,000 — $ 6,720 — — $ — $ 53,720

are entitled to reimbursement of ordinary and reasonable expenses incurred in exercising their responsibilities and duties as

July 1, 2015, the Board approved the following compensation plan for the independent directors payable in accordance with each

independent director’s services agreement:

$30,000 per year for their services rendered on the Board, $15,000 per year for

service as the audit committee chair, $10,000 per year for service as the compensation committee chair, $6,000 per year for service

on the audit committee, $4,000 per year for service on the compensation committee, $2,500 per year for service on the nominating

committee, a one-time non-qualified stock option grant to purchase 20,000 shares (on a pre-Reverse Splits basis) of the Company’s

common stock under the 2011 Plan and restricted stock awards of 20,000 shares (on a pre-Reverse Splits basis) of common stock

under the 2011 Plan, which are granted in four equal installments on a quarterly basis and are each 100% vested upon grant.

January 25, 2019, each independent director entered into an amendment to his respective director services agreement pursuant to

which the Company agreed to grant each independent director, so long as such director continues to fulfill his duties and provide

services pursuant to their services agreement, an annual non-qualified stock option to purchase up to 20,000 shares of common

stock in lieu of the above-mentioned equity awards.

Each stock option grant will be subject to the approval of the Board, which

shall determine the appropriate vesting schedule, if any, and the exercise price.

During the year ended

December 31, 2019, the independent directors received 445 non-qualified stock options and did not receive any restricted stock

Directors are entitled to reimbursement of ordinary and reasonable expenses incurred in exercising their responsibilities and duties as a director.

Effective July 1, 2015, the Board approved the following compensation plan for the independent directors payable in accordance with each independent director’s services agreement:

$30,000 per year for their services rendered on the Board, $15,000 per year for service as the audit committee chair, $10,000 per year for service as the compensation committee chair, $6,000 per year for service on the audit committee, $4,000 per year for service on the compensation committee, $2,500 per year for service on the nominating committee, a one-time non-qualified stock option grant to purchase 20,000 shares (on a pre-Reverse Splits basis) of the Company’s common stock under the 2011 Plan and restricted stock awards of 20,000 shares (on a pre-Reverse Splits basis) of common stock under the 2011 Plan, which are granted in four equal installments on a quarterly basis and are each 100% vested upon grant.

On January 25, 2019, each independent director entered into an amendment to his respective director services agreement pursuant to which the Company agreed to grant each independent director, so long as such director continues to fulfill his duties and provide services pursuant to their services agreement, an annual non-qualified stock option to purchase up to 20,000 shares of common stock in lieu of the above-mentioned equity awards.

Each stock option grant will be subject to the approval of the Board, which shall determine the appropriate vesting schedule, if any, and the exercise price.

During the year ended December 31, 2020, the independent directors received 20,000 non-qualified stock options and did not receive any restricted stock awards.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

following table sets forth certain information as of February 16, 2020, regarding the beneficial ownership of our common stock

by the following persons:

The following table sets forth certain information as of March 5, 2021, regarding the beneficial ownership of our common stock by the following persons:

• our Named Executive Officers;

• each director;

all of our executive officers and directors

each person or entity who, to our knowledge,

owns more than 5% of our common stock.

as indicated in the footnotes to the following table, subject to applicable community property laws, each stockholder named in

the table has sole voting and investment power.

Unless otherwise indicated, the address for each stockholder listed is c/o Inpixon,

• all of our executive officers and directors as a group;

• each person or entity who, to our knowledge, owns more than 5% of our common stock.

Except as indicated in the footnotes to the following table, subject to applicable community property laws, each stockholder named in the table has sole voting and investment power.

Unless otherwise indicated, the address for each stockholder listed is c/o Inpixon, 2479 E.

Bayshore Road, Suite 195, Palo Alto, California 94303.

Shares of common stock subject to options, warrants, or other rights

currently exercisable or exercisable within 60 days of February 16, 2020, are deemed to be beneficially owned and outstanding

for computing the share ownership and percentage of the stockholder holding the options, warrants or other rights, but are not

deemed outstanding for computing the percentage of any other stockholder.

The information provided in the following table is based

on our records, information filed with the SEC, and information furnished by our stockholders.

Name of Beneficial Owner

Amount and nature of beneficial ownership

Shares of common stock subject to options, warrants, or other rights currently exercisable or exercisable within 60 days of March 5, 2021, are deemed to be beneficially owned and outstanding for computing the share ownership and percentage of the stockholder holding the options, warrants or other rights, but are not deemed outstanding for computing the percentage of any other stockholder.

The information provided in the following table is based on our records, information filed with the SEC, and information furnished by our stockholders.

Name of Beneficial Owner Amount and nature of beneficial ownership Percent of Class(1)

Named Executive Officers and Directors

Nadir Ali 2,022,543 (2) 1.9 %

Leonard Oppenheim 60,449 (3) *

Kareem Irfan 60,448 (4) *

Tanveer Khader 60,451 (5) *

Soumya Das 1,013,526 (6) *

Tyler Hoffman 525,000 (7) *

Wendy Loundermon 1,015,786 (8) *

All executive officers and directors as a group (7 persons) 4,758,203 (9) 4.5 %

Represents beneficial

ownership of less than 1%.

(1) Based on 5,049,062 shares outstanding as of February 16, 2020.

(2) Includes (i) 2 shares of common stock held of record by Nadir Ali, (ii) 21,614 shares of common

stock issuable upon exercise of options exercisable within 60 days of February 16, 2020, (iii) 1 shares of common stock held of

record by Lubna Qureishi, Mr.

Ali’s wife, and (iv) 1 shares of common stock held of record by the Qureishi Ali Grandchildren

Trust, of which Mr.

Ali is the joint-trustee (with his wife Lubna Qureishi) of the Qureishi Ali Grandchildren Trust and has shared

voting and investment control over the shares held.

* Represents beneficial ownership of less than 1%.

(1) Based on 101,382,447 shares outstanding as of March 5, 2021.

(2) Includes (i) 1,500,002 shares of common stock held of record by Nadir Ali, which includes 1,500,000 shares of common stock issuable pursuant to a restricted stock grant, subject to certain tax withholding and forfeiture provisions (ii) 522,539 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021, (iii) 1 shares of common stock held of record by Lubna Qureishi, Mr.

Ali’s wife, and (iv) 1 shares of common stock held of record by the Qureishi Ali Grandchildren Trust, of which Mr.

Ali is the joint-trustee (with his wife Lubna Qureishi) of the Qureishi Ali Grandchildren Trust and has shared voting and investment control over the shares held.

Excludes an additional 500,000 shares of common stock underlying options that are not exercisable within 60 days of March 5, 2021.

(3) Includes (i) 2 shares of common stock held of record by Mr.

Oppenheim, and (ii) 447 shares of common

stock issuable upon exercise of options exercisable within 60 days of February 16, 2020.

Oppenheim, and (ii) 60,447 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

(4) Includes (i) 1 shares of common stock held of record by Mr.

Irfan and (ii) 447 shares of common

stock issuable upon exercise of options exercisable within 60 days of February 16, 2020.

(5) Includes (i) 3 shares of common stock owned directly by SyHolding Corp., (ii) 1 shares of common

stock held of record by Mr.

Khader and (iii) 447 shares of common stock issuable upon exercise of options exercisable within 60

days of February 16, 2020.

Irfan and (ii) 60,447 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

(5) Includes (i) 3 shares of common stock owned directly by SyHolding Corp., (ii) 1 shares of common stock held of record by Mr.

Khader and (iii) 60,447 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

Tanveer Khader holds the power to vote and dispose of the SyHolding Corp.

(6) Includes (i) 750,001 shares of common stock held of record by Mr.

Das and (ii) 12,967 shares of common

stock issuable upon exercise of options exercisable within 60 days of February 16, 2020.

Das, which includes 750,000 shares of common stock issuable pursuant to a restricted stock grant, subject to certain tax withholding and forfeiture provisions and (ii) 263,525 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

Excludes an additional 250,000 shares of common stock underlying options that are not exercisable within 60 days of March 5, 2021.

(7) Includes (i) 450,000 shares of common stock held of record by Mr.

Hoffman which includes 450,000 shares of common stock issuable pursuant to a restricted stock grant, subject to certain tax withholding and forfeiture provisions and (ii) 75,000 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021 held by Mr.

Excludes an additional 225,000 shares of common stock underlying options that are not exercisable within 60 days of March 5, 2021.

(8) Includes (i) 750,002 shares of common stock held of record by Ms.

Loundermon and (ii) 15,133 shares of

common stock issuable upon exercise of options exercisable within 60 days of February 16, 2020.

(8) Includes (i) 10 shares of common stock held directly, or by spouse or relative, (ii) 4 shares of

common stock held of record by entities, and (iii) 51,054 shares of common stock issuable upon exercise of options exercisable

within 60 days of February 16, 2020.

Loundermon which includes 750,000 shares of common stock issuable pursuant to a restricted stock grant, subject to certain tax withholding and forfeiture provisions and (ii) 265,784 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

Excludes an additional 250,000 shares of common stock underlying options that are not exercisable within 60 days of March 5, 2021.

(9) Includes (i) 3,450,010 shares of common stock held directly, or by spouse or relative, (ii) 4 shares of common stock held of record by entities, and (iii) 1,308,189 shares of common stock issuable upon exercise of options exercisable within 60 days of March 5, 2021.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Approval or Ratification of Transactions with Related Persons.

Board reviews issues involving potential conflicts of interest, and reviews and approves all related party transactions, including

those required to be disclosed as a “related party”

transaction under applicable federal securities laws.

has not adopted any specific procedures for conducting reviews of potential conflicts of interest and considers each transaction

in light of the specific facts and circumstances presented.

However, to the extent a potential related party transaction is presented

to the Board, the Company expects that the Board would become fully informed regarding the potential transaction and the interests

of the related party, and would have the opportunity to deliberate outside of the presence of the related party.

The Company expects

that the Board would only approve a related party transaction that was in the best interests of the Company, and further would

seek to ensure that any completed related party transaction was on terms no less favorable to the Company than could be obtained

in a transaction with an unaffiliated third party.

Other than as described below, no transaction requiring disclosure under applicable

federal securities laws occurred during fiscal year 2018 that was submitted to the Board for approval as a “related party”

Party Transactions

regulations define the related person transactions that require disclosure to include any transaction, arrangement or relationship

in which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for

the last two completed fiscal years in which we were or are to be a participant and in which a related person had or will have

a direct or indirect material interest.

Review, Approval or Ratification of Transactions with Related Persons.

The Board reviews issues involving potential conflicts of interest, and reviews and approves all related party transactions, including those required to be disclosed as a “related party” transaction under applicable federal securities laws.

The Board has not adopted any specific procedures for conducting reviews of potential conflicts of interest and considers each transaction in light of the specific facts and circumstances presented.

However, to the extent a potential related party transaction is presented to the Board, the Company expects that the Board would become fully informed regarding the potential transaction and the interests of the related party, and would have the opportunity to deliberate outside of the presence of the related party.

The Company expects that the Board would only approve a related party transaction that was in the best interests of the Company, and further would seek to ensure that any completed related party transaction was on terms no less favorable to the Company than could be obtained in a transaction with an unaffiliated third party.

Other than as described below, no transaction requiring disclosure under applicable federal securities laws occurred during fiscal year 2020 that was submitted to the Board for approval as a “related party” transaction.

Related Party Transactions

SEC regulations define the related person transactions that require disclosure to include any transaction, arrangement or relationship in which the amount involved exceeds the lesser of $120,000 or one percent of the average of our total assets at year-end for the last two completed fiscal years in which we were or are to be a participant and in which a related person had or will have a direct or indirect material interest.

A related person is:

(i) an executive officer, director or director nominee, (ii) a beneficial

owner of more than 5% of our common stock, (iii) an immediate family member of an executive officer, director or director nominee

or beneficial owner of more than 5% of our common stock, or (iv) any entity that is owned or controlled by any of the foregoing

persons or in which any of the foregoing persons has a substantial ownership interest or control.

the period from January 1, 2018, through the date of this report (the “Reporting Period”), described below are certain

transactions or series of transactions between us and certain related persons.

(i) an executive officer, director or director nominee, (ii) a beneficial owner of more than 5% of our common stock, (iii) an immediate family member of an executive officer, director or director nominee or beneficial owner of more than 5% of our common stock, or (iv) any entity that is owned or controlled by any of the foregoing persons or in which any of the foregoing persons has a substantial ownership interest or control.

For the period from January 1, 2019, through the date of this report (the “Reporting Period”), described below are certain transactions or series of transactions between us and certain related persons.

Sysorex Transactions

Ali, Chief Executive Officer and member of the Board, is also a member of the board of directors of Sysorex.

Transition Agreements

to the terms of those certain employee transition agreements entered into between the Company and Sysorex, effective as of August

31, 2018 (collectively, the “Transition Agreements”), Sysorex agreed to furnish to the Company, on a transitional

basis, the services of certain of its employees and keep such employees’

on its payroll and benefits plans from August 31,

2018 through and including December 31, 2018 (the “Transitional Period”).

The Company agreed to reimburse Sysorex

for all costs and expenses incurred by Sysorex with respect to such employees’

employment during the Transitional Period.

Sysorex agreed to invoice the Company upon the calculation of amounts owed for the foregoing costs, and the Company agreed

to reimburse Sysorex for all such costs within 3 days of its receipt of each such invoice, plus an administrative service

fee of 2% of the gross amount of each respective invoice;

provided, however, that Sysorex agreed waive such fee for

so long as any Company employees are providing any necessary administrative services on behalf of and for the benefit of Sysorex,

including any employees that are furnished to the Company in accordance with the Transition Agreements.

Revolving Loan

December 31, 2018, the Company and Sysorex entered into a note purchase agreement (the “Note Purchase Agreement”)

pursuant to which the Company agreed to purchase from Sysorex at a purchase price equal to the Loan Amount (as defined below),

a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of $3 million (the “Principal

Amount”), including any amounts advanced through the date of the Secured Note (the “Prior Advances”), to be

borrowed and disbursed in increments (such borrowed amount, together with the Prior Advances, collectively referred to as the

“Loan Amount”), with interest to accrue at a rate of 10% percent per annum on all such Loan Amounts, beginning as

of the date of disbursement with respect to any portion of such Loan Amount.

In addition, Sysorex agreed to pay $20,000 to the

Company to cover the Company’s legal fees, accounting costs, due diligence, monitoring and other transaction costs incurred

in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount

is included in the Principal Amount.

Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding

balance, exclusive of any unpaid accrued interest, not to exceed the Principal Amount at any one time.

sums advanced by the Company to the Maturity Date (as defined below) pursuant to the terms of the Note Purchase Agreement will

become part of the aggregate Loan Amount underlying the Secured Note.

All outstanding principal amounts and accrued unpaid interest

owing under the Secured Note shall become immediately due and payable on the earlier to occur of (i) 24 month anniversary of the

date the Secured Note is issued (the “Maturity Date”), (ii) at such date when declared due and payable by the Company

upon the occurrence of an Event of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in

the Secured Note.

Nadir Ali, Chief Executive Officer and member of the Board, is also a member of the board of directors of Sysorex.

Sysorex Revolving Loan

On December 31, 2018, the Company and Sysorex entered into a note purchase agreement (the “Note Purchase Agreement”) pursuant to which the Company agreed to purchase from Sysorex at a purchase price equal to the Loan Amount (as defined below), a secured promissory note (the “Secured Note”) for up to an aggregate principal amount of $3 million (the “Principal Amount”), including any amounts advanced through the date of the Secured Note (the “Prior Advances”), to be borrowed and disbursed in increments (such borrowed amount, together with the Prior Advances, collectively referred to as the “Loan Amount”), with interest to accrue at a rate of 10% percent per annum on all such Loan Amounts, beginning as of the date of disbursement with respect to any portion of such Loan Amount.

In addition, Sysorex agreed to pay $20,000 to the Company to cover the Company’s legal fees, accounting costs, due diligence, monitoring and other transaction costs incurred in connection with the purchase and sale of the Secured Note (the “Transaction Expense Amount”), all of which amount is included in the Principal Amount.

Sysorex may borrow repay and borrow under the Secured Note, as needed, for a total outstanding balance, exclusive of any unpaid accrued interest, not to exceed the Principal Amount at any one time.

All sums advanced by the Company to the Maturity Date (as defined below) pursuant to the terms of the Note Purchase Agreement will become part of the aggregate Loan Amount underlying the Secured Note.

All outstanding principal amounts and accrued unpaid interest owing under the Secured Note shall become immediately due and payable on the earlier to occur of (i) 24 month anniversary of the date the Secured Note is issued (the “Maturity Date”), (ii) at such date when declared due and payable by the Company upon the occurrence of an Event of Default (as defined in the Secured Note), or (iii) at any such earlier date as set forth in the Secured Note.

All accrued unpaid interest shall be payable in cash.

On February 4, 2019, the Secured Note was amended to increase

the maximum principal amount that may be outstanding at any time under the Secured Note from $3 million to $5 million.

2, 2019, the Secured Note was amended to increase the maximum principal amount that may be outstanding at any time under the Secured

Note from $5 million to $8 million.

On May 22, 2019, the Secured Note was amended to increase the maximum principal amount that

may be outstanding at any time under the Secured Note from $8 million to $10 million.

The largest aggregate principal amount owed

by Sysorex to the Company during the Reporting Period was approximately $10 million, the amount of principal paid during the Reporting

Period was approximately $1.8 million and the interest paid during the Reporting Period was $0.

The amount owed by Sysorex to

the Company as of December 31, 2019 was approximately $10.6 million.

The Secured Note has been classified as “held for sale”

and the Company, with the assistance of a third-party valuation firm, estimated the fair value of such using Sysorex financial

projections, a discounted cash flow model and a 12.3% discount rate.

As a result, the Company established a full valuation allowance

as of December 31, 2019.

We are required to periodically re-evaluate the carrying value of the note and the related valuation

allowance based on various factors, including, but not limited to, Sysorex’s performance and collectability of the note.

Sysorex’s performance against those financial projections will directly impact future assessments of the fair value of the

On March 1, 2020, the Company amended the Secured Note to extend the maturity date of the Secured Note to December 31, 2022,

to increase the default interest rate from 18% to 21% or the maximum rate allowable by law and to require a cash payment to the

Company by Sysorex against the Loan Amount in an amount equal to no less than 6% of the aggregate gross proceeds raised following

the completion of any financing, or series of related financings, in which Sysorex raises aggregate gross proceeds of at least

On February 20, 2019,

the Company, Sysorex and Atlas Technology Group, LLC (“Atlas”) entered into a settlement agreement resulting in a net

award of $941,796 whereby Atlas agreed to accept an aggregate of 16,655 shares of freely-tradable common stock of the Company in

full satisfaction of the award.

The Company and Sysorex each agreed pursuant to the terms and conditions of that certain

Separation and Distribution Agreement, dated August 7, 2018, as amended, that 50% of the costs and liabilities related to the arbitration

action would be shared by each party following the Spin-off.

As a result, Sysorex owes the Company $559,121 for the settlement

plus the interest accrued during the fiscal year ended December 31, 2019 of $57,238.

There were no repayments during 2019,

the highest balance during the fiscal year ended December 31, 2019 was $616,359 and total owed to the Company for this settlement

as of December 31, 2019 was $616,359.

On February 4, 2019, the Secured Note was amended to increase the maximum principal amount that may be outstanding at any time under the Secured Note from $3 million to $5 million.

On April 2, 2019, the Secured Note was amended to increase the maximum principal amount that may be outstanding at any time under the Secured Note from $5 million to $8 million.

On May 22, 2019, the Secured Note was amended to increase the maximum principal amount that may be outstanding at any time under the Secured Note from $8 million to $10 million.

The largest aggregate principal amount owed by Sysorex to the Company during the Reporting Period was approximately $10 million, the amount of principal paid during the Reporting Period was approximately $1.8 million and the interest paid during the Reporting Period was $0.

The amount owed by Sysorex to the Company as of December 31, 2020 was approximately $7.7 million.

These amounts exclude $275,000 of additional interest that the Company is contractually entitled to accrue from October 1, 2019 through December 31, 2019 and approximately $1.1 million of additional interest from January 1, 2020 through December 31, 2020 in accordance with the terms of the Sysorex Note, but did not accrue due to the uncertainty of repayment.

The Secured Note has been classified as “held for sale” and the Company, with the assistance of a third-party valuation firm, estimated the fair value of such using Sysorex financial projections, a discounted cash flow model and a 12.3% discount rate.

As a result, the Company established a full valuation allowance as of December 31, 2020.

We are required to periodically re-evaluate the carrying value of the note and the related valuation allowance based on

various factors, including, but not limited to, Sysorex’s performance and collectability of the note.

Sysorex’s performance against those financial projections will directly impact future assessments of the fair value of the note.

On March 1, 2020, the Company amended the Secured Note to extend the maturity date of the Secured Note to December 31, 2022, to increase the default interest rate from 18% to 21% or the maximum rate allowable by law and to require a cash payment to the Company by Sysorex against the Loan Amount in an amount equal to no less than 6% of the aggregate gross proceeds raised following the completion of any financing, or series of related financings, in which Sysorex raises aggregate gross proceeds of at least $5 million.

Sysorex Receivable

On February 20, 2019, the Company, Sysorex and Atlas Technology Group, LLC (“Atlas”) entered into a settlement agreement resulting in a net award of $941,796 whereby Atlas agreed to accept an aggregate of 16,655 shares of freely-tradable common stock of the Company in full satisfaction of the award.

The Company and Sysorex each agreed pursuant to the terms and conditions of that certain Separation and Distribution Agreement, dated August 7, 2018, as amended, that 50% of the costs and liabilities related to the arbitration action would be shared by each party following the Spin-off.

As a result, Sysorex owes the Company $616,359 as of December 31, 2019 for the settlement plus the interest accrued during the fiscal year ended December 31, 2020 of $31,824.

There were no repayments during 2020, the highest balance during the fiscal year ended December 31, 2020 was $648,183 and total owed to the Company for this settlement as of December 31, 2020 was $648,183.

Systat License Acquisition

On June 19, 2020, we entered into an exclusive license to market, distribute, and develop the SYSTAT and SigmaPlot software suite of products (the “License Grant”) pursuant to the terms and conditions of that certain Exclusive Software License and Distribution Agreement, as amended on June 30, 2020 (as amended, the “License Agreement”), with Cranes Software International Ltd.

(“Cranes”) and Systat Software, Inc.

(“Systat,” and together with Cranes, the “Systat Parties”).

In accordance with the terms of the License Agreement, on June 30, 2020 (the “License Closing Date”), we acquired the License Grant, effective as of June 1, 2020, and we partitioned a portion of the outstanding balance under that certain promissory note (the “Sysorex Note”) issued to us by Sysorex, Inc.

(“Sysorex”), into a new note in an amount equal to $3 million in principal plus accrued interest (the “Closing Note”) and assigned the Closing Note and all rights and obligations thereunder to Systat in accordance with the terms and conditions of that certain Promissory Note Assignment and Assumption Agreement (the "Assignment Agreement").

An additional $3.3 million of the principal balance underlying the Sysorex Note was partitioned and assigned to Systat as consideration payable for the rights granted under the license, including $1.3 million on the three month anniversary of the License Closing Date, $1.0 million on the six month anniversary of the License Closing Date and an additional $1.0 million on March 19, 2021.

Each assignment under the Sysorex Note was represented by a new secured promissory note and our right to any repayment under the Sysorex Note is subordinate and junior to Sysorex’s obligation to make any payment to Systat unless we have exercised our right to offset any losses against such assigned notes as permitted in the License Agreement.

In addition, we paid the remaining cash consideration of $2.2 million for the License Grant on July 8, 2020.

In connection with the License Grant, the Systat Parties provided us with equipment for us to use at no additional cost for a minimum period of six months following the License Closing Date.

In addition, we have the right, but not the obligation, to assume all of the Systat Parties’ rights, interests, and obligations under the Systat Customer Contracts and the Systat Distribution Agreements (as such terms are defined in the License Agreement).

We are also entitled to any customer maintenance revenue, new license fees, or license renewal fees, received by any of the Systat Parties after June 1, 2020 in connection with the Systat Customer Contracts and/or Systat Distribution Agreements assigned to and assumed by us in connection with the License Agreement.

The License Grant will remain in effect for a period of 15 years following the License Closing Date (the “Term”), unless terminated sooner upon mutual written consent of Systat and us or upon termination by either for the other party’s specified breach.

At any time during the first 5-year period of the Term (the "Purchase Option Exercise Period"), we may exercise our option to purchase the Software, Software Source, User Documentation, Systat Intellectual Property, Customer Information and Equipment (as such terms are defined in the License Agreement) from the Systat Parties in exchange for an assignment of our right to receive an additional $1.0 million in principal under the Sysorex Note.

On February 22, 2021, we entered into a Second Amendment to the License Agreement to allow for the exercise of the purchase option in whole or in part any time during the Purchase Option Period and to provide for cash consideration in lieu of an assignment of the Sysorex Note at our option.

In addition, we exercised our option to purchase a portion of the underlying assets, including certain software, trademarks, solutions, domain names and websites from Systat in exchange for consideration in an amount equal to $900,000.

Nadir Ali, our Chief Executive Officer and a member of our Board, is a related party in connection with the acquisition of the Licenses as a result of his service as a director of Sysorex, the issuer of the Sysorex Note that was assigned in accordance with the terms and conditions of the License Agreement.

In addition, Tanveer Khader and Kareem Irfan, members of our Board, are also related parties in connection with the acquisition of the Licenses as a result of their respective employment relationships with the Systat Parties.

Subscription of Units of Cardinal Venture Holdings

On September 30, 2020, we entered into a Subscription Agreement (the “Subscription Agreement”) with Cardinal Venture Holdings LLC, a Delaware limited liability company (“CVH”), pursuant to which we agreed to (i) contribute up to $1,800,000 (the “Contribution”) to CVH and (ii) purchase up to 599,999 Class A Units of CVH (the “Class A Units”) and up to 1,800,000 Class B Units of CVH (the “Class B Units,” and, together with the Class A Units, the “Units”).

The aggregate purchase price of $1,800,000 for the Units is deemed to be satisfied in part through the Contribution.

CVH owns certain interests in the sponsor entity (the “Sponsor”) to a special purpose acquisition company formed for the purpose of pursuing an initial public offering of its securities followed by effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “SPAC”).

It is anticipated that the Contribution will be used by CVH to fund the Sponsor’s purchase of securities in the SPAC.

Nadir Ali, our Chief Executive Officer and a director, beneficially owns membership interests in CVH through 3AM LLC, a Delaware limited liability company and a founding member of CVH (“3AM”).

Concurrently with our entry into the Subscription Agreement, we entered into the Amended and Restated Limited Liability Company Agreement of CVH (the “LLC Agreement”), dated as of September 30, 2020.

Under the terms of the LLC Agreement, in the event the Managing Member (as defined in the LLC Agreement) can no longer manage CVH’s affairs due to his death, disability or incapacity, 3AM will serve as CVH’s replacement Managing Member.

Except as may be required by law, we, as a non-managing member under the LLC Agreement, do not have any voting rights and generally cannot take part in the management or control of CVH’s business and affairs.

The LLC Agreement provides that each Class A Unit and each Class B Unit represents the right of the Company to receive any distributions made by the Sponsor on account of the Class A Interests and Class B Interests, respectively, of the Sponsor.

We not required to make additional capital contributions to CVH, unless any such capital contribution is approved by all of CVH’s members.

In addition, the LLC Agreement contains terms and conditions that provide for limitations on liability, restrictions on rights to distributions and certain indemnification rights for CVH’s members.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

forth below are approximate fees for services rendered by Marcum LLP, our independent registered public accounting firm, for the

fiscal years ended December 31, 2019 and 2018.

Set forth below are approximate fees for services rendered by Marcum LLP, our independent registered public accounting firm, for the fiscal years ended December 31, 2020 and 2019.

Audit Fees(1) $ 355,024 $ 399,382

Audit Related Fees $ — $ —

Tax Fees $ — $ —

All Other Fees $ — $ —

Audit fees represent

fees for professional services provided in connection with the audit of our financial statements and review of our quarterly

financial statements and audit services provided in connection with other statutory or regulatory filings.

The “Audit Fees”

are the aggregate fees of Marcum attributable to professional services rendered in 2019

and 2018 for the audit of our annual financial statements, for review of financial statements included in our quarterly reports

on Form 10-Q or for services that are normally provided by Marcum in connection with statutory and regulatory filings or engagements

for that fiscal year.

These fees include fees billed for professional services rendered by Marcum for the review of registration

statements or services that are normally provided in connection with statutory and regulatory filings or engagements for those

fiscal years.

Audit-Related

Marcum billed us for professional services that were reasonably related to the performance of the audit or review of

financial statements in 2019 and 2018, which are not included under Audit Fees above including the filing of our registration

statements, including our Registration Statement on Form S-3.

(1) Audit fees represent fees for professional services provided in connection with the audit of our financial statements and review of our quarterly financial statements and audit services provided in connection with other statutory or regulatory filings.

The “Audit Fees” are the aggregate fees of Marcum attributable to professional services rendered in 2020 and 2019 for the audit of our annual financial statements, for review of financial statements included in our quarterly reports on Form 10-Q or for services that are normally provided by Marcum in connection with statutory and regulatory filings or engagements for that fiscal year.

These fees include fees billed for professional services rendered by Marcum for the review of registration statements or services that are normally provided in connection with statutory and regulatory filings or engagements for those fiscal years.

Audit-Related Fees .

Marcum billed us for professional services that were reasonably related to the performance of the audit or review of financial statements in 2020 and 2019, which are not included under Audit Fees above including the filing of our registration statements, including our Registration Statement on Form S-3.

This amount also includes audit fees related to acquisitions.

Marcum did not perform any tax advice or planning services in 2020 or 2019.

Marcum did not perform any services for us or charge any fees other than the services described above in 2019

Policies and Procedures

Audit Committee is required to review and approve in advance the retention of the independent auditors for the performance of

all audit and lawfully permitted non-audit services and the fees for such services.

The Audit Committee may delegate to one or

more of its members the authority to grant pre-approvals for the performance of non-audit services, and any such Audit Committee

member who pre-approves a non-audit service must report the pre-approval to the full Audit Committee at its next scheduled meeting.

All Other Fees .

Marcum did not perform any services for us or charge any fees other than the services described above in 2020 and 2019.

Pre-approval Policies and Procedures

The Audit Committee is required to review and approve in advance the retention of the independent auditors for the performance of all audit and lawfully permitted non-audit services and the fees for such services.

The Audit Committee may delegate to one or more of its members the authority to grant pre-approvals for the performance of non-audit services, and any such Audit Committee member who pre-approves a non-audit service must report the pre-approval to the full Audit Committee at its next scheduled meeting.

The Audit Committee is required to periodically notify the Board of their approvals.

The required pre-approval policies and procedures

were complied with during 2019.

The required pre-approval policies and procedures were complied with during 2020.

Exhibits, Financial Statement Schedules

Financial Statements

financial statements filed as part of this report are listed and indexed in the table of contents.

Financial statement schedules

have been omitted because they are not applicable or the required information has been included elsewhere in this report.

Financial Statement Schedules

exhibits filed as part of this Annual Report on Form 10-K are listed in the Exhibit Index immediately preceding the exhibits.

The Company has identified in the Exhibit Index each management contract and compensation plan filed as an exhibit to this Annual

Report on Form 10-K in response to Item 15(a)(3) of Form 10-K.

15(a)(1) Financial Statements

The financial statements filed as part of this report are listed and indexed in the table of contents.

Financial statement schedules have been omitted because they are not applicable or the required information has been included elsewhere in this report.

15(a)(2) Financial Statement Schedules

Not applicable.

15(a)(3) Exhibits

The exhibits filed as part of this Annual Report on Form 10-K are listed in the Exhibit Index immediately preceding the exhibits.

The Company has identified in the Exhibit Index each management contract and compensation plan filed as an exhibit to this Annual Report on Form 10-K in response to Item 15(a)(3) of Form 10-K.

FORM 10-K SUMMARY.

to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report

to be signed on its behalf by the undersigned, thereunto duly authorized.

March 3, 2020

Not applicable.

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

March 31, 2021 By:

/s/ Nadir Ali

Chief Executive Officer

person whose signature appears below constitutes and appoints Nadir Ali and Wendy Loundermon, and each of them, as his or her

true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her

name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file

the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission,

granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act

and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might

or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or

his substitutes, may lawfully do or cause to be done by virtue thereof.

to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf

of the registrant and in the capacities and on the dates indicated:

Chief Executive Officer and Director

March 3, 2020

(Principal Executive Officer)

Wendy Loundermon

Chief Financial Officer and Director

March 3, 2020

Wendy Loundermon

(Principal Financial and Accounting Officer)

March 3, 2020

Tanveer Khader

March 3, 2020

Each person whose signature appears below constitutes and appoints Nadir Ali and Wendy Loundermon, and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes, may lawfully do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:

Signature Title Date

/s/ Nadir Ali Chief Executive Officer and Director March 31, 2021

Nadir Ali (Principal Executive Officer)

/s/ Wendy Loundermon Chief Financial Officer and Director March 31, 2021

Wendy Loundermon (Principal Financial and Accounting Officer)

/s/ Leonard A.

Oppenheim Director March 31, 2021

/s/ Kareem Irfan Director March 31, 2021

/s/ Tanveer Khader Director March 31, 2021

Tanveer Khader

EXHIBIT INDEX

Exhibit Description

Equity Distribution Agreement, by and between Inpixon and Maxim Group LLC, dated as of March 3, 2020

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

2.1† Asset Purchase and Merger Agreement dated March 1, 2013 by and among Sysorex Global Holdings Corp., Lilien, LLC and Lilien Systems.

S-1 333-190574

2.1 August 12, 2013

1 unchanged sentence

and the Shareholder Representative.

October 9, 2013

S-1 333-191648 2.4 October 9, 2013

2.3 Agreement and Plan of Merger dated as of December 20, 2013, by and among Sysorex Global Holdings Corp., AirPatrol Corporation, AirPatrol Acquisition Corp.

1 unchanged sentence

II, and Shareholders Representative Services LLC.

January 21, 2014

S-1/A 333-191648 2.6 January 21, 2014

2.4 Amendment No.

1 to Agreement and Plan of Merger dated February 28, 2014 with AirPatrol Corporation.

March 13, 2014

S-1/A 333-191648 2.7 March 13, 2014

2.5 Amendment No.

2 to Agreement and Plan of Merger dated April 18, 2014 with AirPatrol Corporation.

8-K 001-36404

2.8 April 24, 2014

1 unchanged sentence

3 to Agreement and Plan of Merger dated May 30, 2014 with AirPatrol Corporation.

S-1 333-198502

12.9 August 29, 2014

1 unchanged sentence

and Chris Baskett.

8-K 001-36404

2.1 April 30, 2015

1 unchanged sentence

and Sysorex Global.

December 18, 2015

8-K 001-36404 10.3 December 18, 2015

2.9† Asset Purchase Agreement, dated November 14, 2016, among Integrio Technologies, LLC, Emtec Federal, LLC, Sysorex Government Services, Inc.

and Sysorex Global.

November 18, 2016

8-K 001-36404 2.1 November 18, 2016

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

2.10 Amendment No.

1 to Asset Purchase Agreement, dated as of November 21, 2016, by and among Sysorex Global, Sysorex Government Services, Inc., Integrio Technologies, LLC and Emtec Federal, LLC.

November 28, 2016

8-K 001-36404 2.2 November 28, 2016

2.11 Agreement and Plan of Merger, dated as of February 27, 2017, between Sysorex Global and Inpixon.

March 1, 2017

8-K 001-36404 2.1 March 1, 2017

2.12 Agreement and Plan of Merger, dated as of July 25, 2018, between Inpixon USA and Sysorex, Inc.

July 31, 2018

8-K 001-36404 2.1 July 31, 2018

2.13 Separation and Distribution Agreement, dated August 7, 2018 between Inpixon and Sysorex, Inc.

August 13, 2018

10-Q 001-36404 2.1 August 13, 2018

2.14 Amendment No.

1 to Separation and Distribution Agreement dated August 31, 2018 between Inpixon and Sysorex, Inc.

September 4, 2018

Share Purchase Agreement, dated May 21, 2019, by and among Inpixon, Inpixon Canada, Inc., Locality Systems Inc., Kirk Moir, in his capacity as the Sellers’

Representative, the Sellers and Garibaldi Capital Advisors Ltd.

8-K 001-36404 10.5 September 4, 2018

2.15† Share Purchase Agreement, dated May 21, 2019, by and among Inpixon, Inpixon Canada, Inc., Locality Systems Inc., Kirk Moir, in his capacity as the Sellers’ Representative, the Sellers and Garibaldi Capital Advisors Ltd.

8-K 001-36404 2.1 May 22, 2019

2.16† Asset Purchase Agreement, dated June 27, 2019, by and between Inpixon and GTX Corp.

Exhibit Description

Share Purchase Agreement, dated July 9, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc., the Vendors, and Chris Wiegand, in his capacity as the Vendors’

Representative.

July 11, 2019

Amendment to Share Purchase Agreement, dated as of August 8, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc., the Vendors, and Chris Wiegand, in his capacity as the Vendors’

Representative.

August 9, 2019

The Second Amendment to the Share Purchase Agreement, dated August 15, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc, and Chris Wiegand, in his capacity as the Vendors’

representative.

August 19, 2019

8-K 001-36404 2.1 July 1, 2019

2.17† Share Purchase Agreement, dated July 9, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc., the Vendors, and Chris Wiegand, in his capacity as the Vendors’ Representative.

8-K 001-36404 2.1 July 11, 2019

2.18† Amendment to Share Purchase Agreement, dated as of August 8, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc., the Vendors, and Chris Wiegand, in his capacity as the Vendors’ Representative.

8-K 001-36404 2.1 August 9, 2019

2.19 The Second Amendment to the Share Purchase Agreement, dated August 15, 2019, by and among Inpixon, Inpixon Canada, Inc., Jibestream Inc, and Chris Wiegand, in his capacity as the Vendors’ representative.

8-K 001-36404 2.1 August 19, 2019

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

2.20† Asset Purchase Agreement, dated as of August 19, 2020, by and among Inpixon, Ten Degrees Inc., Ten Degrees International Limited, mCube International Limited and mCube, Inc.

8-K 001-36404 2.1 August 20, 2020

2.21† Share Sale and Purchase Agreement, dated as of October 5, 2020, among Inpixon GmbH, Sensera Limited and Nanotron Technologies GmbH.

8-K 001-36404 2.1 October 5, 2020

2.22 Amendment to the Share Sale and Purchase Agreement, dated as of February 24, 2021, among Inpixon GmbH, Sensera Limited and Nanotron Technologies GmbH.

8-K 001-36404 2.1 February 26, 2021

Stock Purchase Agreement, dated as of March 25, 2021, among Inpixon, Game Your Game, Inc., Rick Clemmer, and Martin Manniche.

3.1 Restated Articles of Incorporation.

August 12, 2013

S-1 333-190574 3.1 August 12, 2013

3.2 Certificate of Amendment to Articles of Incorporation (Increase Authorized Shares).

S-1 333-218173 3.2 May 22, 2017

3.3 Certificate of Amendment to Articles of Incorporation (Reverse Split).

April 10, 2014

8-K 001-36404 3.1 April 10, 2014

3.4 Articles of Merger (renamed Sysorex Global).

December 18, 2015

8-K 001-36404 3.1 December 18, 2015

3.5 Articles of Merger (renamed Inpixon).

March 1, 2017

8-K 001-36404 3.1 March 1, 2017

3.6 Certificate of Amendment to Articles of Incorporation (Reverse Split).

March 1, 2017

8-K 001-36404 3.2 March 1, 2017

3.7 Certificate of Amendment to Articles of Incorporation (authorized share increase).

February 5, 2018

8-K 001-36404 3.1 February 5, 2018

3.8 Certificate of Amendment to Articles of Incorporation (Reverse Split).

February 6, 2018

8-K 001-36404 3.1 February 6, 2018

3.9 Certificate of Amendment to Articles of Incorporation (Reverse Split).

November 1, 2018

8-K 001-36404 3.1 November 1, 2018

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

3.10 Certificate of Amendment to Articles of Incorporation, effective as of January 7, 2020 (Reverse Split).

January 7, 2020

8-K 001-36404 3.1 January 7, 2020

3.11 Bylaws, as amended.

August 12, 2013

S-1 333-190574 3.2 August 12, 2013

4.1 Specimen Stock Certificate of the Company.

August 12, 2013

S-1 333-190574 4.1 August 12, 2013

4.2 Form of Certificate of Designation of Preferences, Rights and Limitations of Series 4 Convertible Preferred Stock.

April 24, 2018

8-K 001-36404 3.1 April 24, 2018

4.3 Certificate of Designation of Series 5 Convertible Preferred Stock, dated as of January 14, 2019.

January 15, 2019

Promissory Note, dated as of October 12, 2018.

October 18, 2018

8-K 001-36404 3.1 January 15, 2019

4.4 Promissory Note, dated as of December 21, 2018.

December 31, 2018

8-K 001-36404 4.1 December 31, 2018

4.5 Warrant to purchase common stock dated March 20, 2013 held by Bridge Bank N.A.

August 12, 2013

Exhibit Description

Warrant to purchase common stock dated August 29, 2013 held by Bridge Bank N.A.

October 9, 2013

S-1 333-190574 4.3 August 12, 2013

4.6 Form of Warrant Agency Agreement

June 23, 2017

S-1/A 333-218173 4.7 June 23, 2017

4.7 Form of Additional Warrant

August 9, 2017

8-K 001-36404 4.1 August 9, 2017

4.8 Form of Warrant

January 9, 2018

8-K 001-36404 4.1 January 9, 2018

4.9 Form of Warrant

February 16, 2018

8-K 001-36404 4.1 February 16, 2018

4.10 Form of Warrant

April 24, 2018

8-K 001-36404 4.1 April 24, 2018

4.11 Form of Warrant

January 15, 2019

8-K 001-36404 4.1 January 15, 2019

4.12 Form of Warrant Agency Agreement

January 15, 2019

8-K 001-36404 4.2 January 15, 2019

4.13 Promissory Note, dated as of May 3, 2019

8-K 001-36404 4.1 May 3, 2019

4.14 Promissory Note, dated as of June 27, 2019.

June 27, 2019

8-K 001-36404 4.1 June 27, 2019

4.15 Form of Series A warrants.

August 14, 2019

8-K 001-36404 4.2 August 14, 2019

4.16 Series 6 Preferred Certificate of Designation, effective as of August 13, 2019.

August 14, 2019

8-K 001-36404 4.1 August 14, 2019

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

4.17 Promissory Note, dated as of August 8, 2019

August 9, 2019

8-K 001-36404 4.1 August 9, 2019

4.18 Promissory Note, dated as of November 22, 2019.

November 22, 2019

Description of Registrant’s Securities

Legal opinion of Mitchell Silberberg & Knupp LLP

8-K 001-36404 4.1 November 22, 2019

4.19 Description of Registrant’s Securities

10-K 001-36404 4.21 March 3, 2020

4.20 Promissory Note, dated as of March 18, 2020.

8-K 001-36404 4.1 March 20, 2020

4.21 Form of Purchase Warrant

8-K 001-36404 4.1 November 27, 2020

4.22 Form of Pre-Funded Warrant

8-K 001-36404 4.2 November 27, 2020

4.23 Form of Purchase Warrant

8-K 001-36404 4.1 January 25, 2021

4.24 Form of Pre-Funded Warrant

8-K 001-36404 4.2 January 25, 2021

4.25 Form of Purchase Warrant

8-K 001-36404 4.1 February 12, 2021

4.26 Form of Pre-Funded Warrant

8-K 001-36404 4.2 February 12, 2021

4.27 Form of Purchase Warrant

8-K 001-36404 4.1 February 17, 2021

4.28 Form of Pre-Funded Warrant

8-K 001-36404 4.2 February 17, 2021

10.1+ Amended and Restated 2011 Employee Stock Incentive Plan.

S-8 333-195655 10.22 May 2, 2014

10.2+ Form of Incentive Stock Option Agreement.

October 27, 2014

8-K 001-36404 10.9 October 27, 2014

10.3+ Form of Non-Qualified Stock Option Agreement.

October 27, 2014

8-K 001-36404 10.5 October 27, 2014

10.4+ Form of Restricted Stock Award Agreement.

October 27, 2014

8-K 001-36404 10.6 October 27, 2014

10.5+ 2018 Employee Stock Incentive Plan, as amended.

November 1, 2019

2018 Employee Stock Incentive Plan Form of Incentive Stock Option Agreement.

S-8 333-234458 99.1 November 1, 2019

10.6+ 2018 Employee Stock Incentive Plan Form of Non-Qualified Stock Option Agreement.

10.7+ 2018 Employee Stock Incentive Plan Form of Non-Qualified Stock Option Agreement.

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

10.8+ 2018 Employee Stock Incentive Plan Form of Restricted Stock Award Agreement.

10.9+ Director Services Agreement with Leonard A.

Oppenheim dated October 21, 2014.

October 27, 2014

Exhibit Description

8-K 001-36404 10.1 October 27, 2014

10.10+ Waiver and Amendment No.

1 unchanged sentence

Oppenheim dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.9 March 28, 2019

10.11+ Director Services Agreement with Kareem M.

Irfan dated October 21, 2014.

October 27, 2014

8-K 001-36404 10.3 October 27, 2014

10.12+ Waiver and Amendment No.

1 unchanged sentence

Irfan dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.11 March 28, 2019

10.13+ Director Services Agreement with Tanveer A.

Khader dated October 21, 2014.

October 27, 2014

8-K 001-36404 10.4 October 27, 2014

10.14+ Waiver and Amendment No.

1 unchanged sentence

Khader dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.13 March 28, 2019

10.15+ Amended and Restated Employment Agreement by and between the Company and Nadir Ali

10-Q 001-36404 10.14 May 15, 2018

10.16+ Employment Agreement, effective as of October 1, 2014, between Wendy Loundermon and the Company.

October 27, 2014

8-K 001-36404 10.8 October 27, 2014

10.17+ Employment Agreement dated November 4, 2016, by and between Sysorex USA and Soumya Das.

April 17, 2017

10-K 001-36404 10.51 April 17, 2017

10.18+ Amended Compensation Terms for Soumya Das

August 13, 2018

10-Q 001-36404 10.9 August 13, 2018

10.19+ Amendment to Employment Agreement dated August 31, 2018 among Inpixon, Sysorex, Inc.

and Soumya Das

September 4, 2018

Amended and Restated GemCap Loan and Security Agreement:

Payplant Loan and Security Agreement, by and among GemCap Lending, LLC, Inpixon, Inpixon USA, Inpixon Federal, Inc.

and Payplant LLC, as agent for Payplant Alternatives Fund LLC.

August 18, 2017

Payplant Client Agreement by and among Inpixon, Inpixon USA, Inpixon Federal, Inc.

and Payplant LLC.

August 18, 2017

Amendment 1 to Payplant Client Agreement dated August 31, 2018 between Inpixon, Sysorex, Inc., Sysorex Government Services, Inc.

and Payplant LLC.

September 4, 2018

Tax Matters Agreement dated August 31, 2018 between Inpixon and Sysorex, Inc.

September 4, 2018

Employee Matters Agreement dated August 31, 2018 between Inpixon and Sysorex, Inc.

September 4, 2018

8-K 001-36404 10.8 September 4, 2018

10.20 Assignment and Assumption Agreement dated August 31, 2018 between members of the Inpixon Group and members of the Sysorex Group

September 4, 2018

8-K 001-36404 10.4 September 4, 2018

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

10.21 Note Purchase Agreement, dated as of December 31, 2018, by and between Inpixon and Sysorex, Inc.

December 31, 2018

Exhibit Description

8-K 001-36404 10.2 December 31, 2018

10.22 Sysorex Secured Promissory Note, dated as of December 31, 2018.

December 31, 2018

8-K 001-36404 10.3 December 31, 2018

10.23 First Amendment Agreement, dated as of February 4, 2019, between Inpixon and Sysorex, Inc.

February 8, 2019

8-K 001-36404 10.2 February 8, 2019

10.24+ Waiver and Amendment No.

1 unchanged sentence

Oppenheim dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.9 March 28, 2019

10.25+ Waiver and Amendment No.

1 unchanged sentence

Irfan dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.11 March 28, 2019

10.26+ Waiver and Amendment No.

1 unchanged sentence

Khader dated February 4, 2019.

March 28, 2019

10-K 001-36404 10.13 March 28, 2019

10.27 Second Amendment Agreement, dated as of April 2, 2019, between Inpixon and Sysorex, Inc.

April 5, 2019

10.32&dagger;

8-K 001-36404 10.1 April 5, 2019

10.28+ Note Purchase Agreement, dated as of May 3, 2019.

8-K 001-36404 10.1 May 3, 2019

10.29# Das Commission Plan.

10-Q 001-36404 10.11 May 14, 2019

10.30 General Security Agreement, dated May 21, 2019, executed by Locality Systems Inc.

in favor of the Sellers.

8-K 001-36404 10.1 May 22, 2019

10.31 Guaranty Agreement, dated May 21, 2019, executed by Inpixon in favor of the Sellers.

8-K 001-36404 10.2 May 22, 2019

10.32 Third Amendment Agreement, dated as of May 22, 2019, between Inpixon and Sysorex, Inc.

8-K 001-36404 10.3 May 22, 2019

10.33 Note Purchase Agreement, dated as of June 27, 2019.

June 27, 2019

10.38&dagger;

8-K 001-36404 10.2 June 27, 2019

10.34† Patent Assignment and License-Back Agreement, dated June 27, 2019, by and between Inpixon and GTX Corp.

10.39&dagger;

8-K 001-36404 10.1 July 1, 2019

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

10.35† Patent License Agreement, dated June 27, 2019, by and between Inpixon and Inventergy .

10.40&dagger;

8-K 001-36404 10.4 July 1, 2019

10.36† Patent License Agreement, dated June 27, 2019, by and between Inpixon and GTX Corp.

8-K 001-36404 10.2 July 1, 2019

10.37 Form of Promissory Note.

10.42&dagger;

8-K 001-36404 10.6 July 1, 2019

10.38† Note Purchase Agreement, dated as of August 8, 2019.

August 9, 2019

8-K 001-36404 10.1 August 9, 2019

10.39 Form of Jibestream Note.

August 9, 2019

10.44&dagger;

8-K 001-36404 10.3 August 9, 2019

10.40† Note Purchase Agreement, dated as of November 22, 2019.

November 22, 2019

8-K 001-36404 10.1 November 22, 2019

10.41 Amendment to Promissory Note.

January 7, 2020

8-K 001-36404 10.1 January 7, 2020

10.42 Fourth Amendment Agreement, dated as of March 1, 2020, between Inpixon and Sysorex, Inc.

10-K 001-36404 10.5 March 3, 2020

10.43 Note Purchase Agreement, dated as of March 18, 2020.

8-K 001-36404 10.1 March 20, 2020

10.44† Exclusive Software License and Distribution Agreement, dated as of June 19, 2020, by and among Inpixon, Cranes Software International Ltd., and Systat Software, Inc.

8-K 001-36404 10.1 June 22, 2020

10.45 Amendment and Waiver to Exclusive Software License & Distribution Agreement, dated as of June 30, 2020, by and among Inpixon, Cranes Software International Ltd., and Systat Software, Inc.

8-K 001-36404 10.1 July 2, 2020

10.46 Promissory Note Assignment and Assumption Agreement, dated as of June 30, 2020, by and between Inpixon, Systat Software, Inc.

and Sysorex, Inc.

8-K 001-36404 10.3 July 2, 2020

10.47 Intercreditor Agreement, dated as of June 30, 2020, among Inpixon, Sysorex, Inc.

and Systat Software, Inc.

8-K 001-36404 10.4 July 2, 2020

10.48+ Employment Agreement, dated May 5, 2020, by and between Inpixon and Tyler Hoffman.

10-Q 001-36404 10.2 August 14, 2020

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

10.49+ Amendment No.

4 to Inpixon 2018 Employee Stock Incentive Plan.

10-Q 001-36404 10.7 August 14, 2020

10.50† Consulting Agreement, dated as of August 19, 2020, by and between Inpixon and mCube, Inc..

8-K 001-36404 10.1 August 20, 2020

10.51# Reseller and Development License Agreement, dated as of August 19, 2020, by and between Inpixon and mCube, Inc.

8-K 001-36404 10.2 August 20, 2020

10.52 Form of Amended and Restated Limited Liability Company Agreement of Cardinal Venture Holdings LLC.

8-K 001-36404 10.2 October 5, 2020

10.53† Form of Purchase Agreement

8-K 001-36404 10.1 January 25, 2021

10.54† Form of Purchase Agreement

8-K 001-36404 10.1 February 12, 2021

10.55† Form of Purchase Agreement

8-K 001-36404 10.1 February 17, 2021

10.56 Amendment #2 to Promissory Note, dated as of March 17, 2021, by and between Inpixon and Iliad Research and Trading, L.P.

8-K 001-36404 10.1 March 19, 2021

21.1 List of Subsidiaries of the Company.

March 28, 2019

23.1 Consent of Marcum LLP.

Consent of Mitchell Silberberg & Knupp LLP (included in Exhibit 5.1)

24.1 Power of Attorney (included on signature page).

Exhibit Description

Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2019.

Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2019.

Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.

31.1 Certification of the Company’s Principal Certification of the Company’s Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2019.

Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2019.

31.2 Certification of the Company’s Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, with respect to the registrant’s Annual Report on Form 10-K for the year ended December 31, 2019.

32.1## Certification of the Company’s Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.

Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

XBRL Instant Document

XBRL Taxonomy Extension Schema Document

XBRL Taxonomy Extension Calculation Linkbase Document

XBRL Taxonomy Extension Definition Linkbase Document

XBRL Taxonomy Extension Label Linkbase Document

XBRL Taxonomy Extension Presentation Linkbase Document

Number Exhibit Description Form File No.

Exhibit Filing Date Filed

101.INS XBRL Instant Document X

101.SCH XBRL Taxonomy Extension Schema Document X

101.CAL XBRL Taxonomy Extension Calculation Linkbase Document X

101.DEF XBRL Taxonomy Extension Definition Linkbase Document X

101.LAB XBRL Taxonomy Extension Label Linkbase Document X

101.PRE XBRL Taxonomy Extension Presentation Linkbase Document X

+ Indicates a management contract or compensatory plan.

† Exhibits, schedules and similar attachments have been omitted pursuant to Item 601 of Regulation S-K and the registrant undertakes to furnish supplemental copies of any of the omitted exhibits and schedules upon request by the SEC.

Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (“[****]”) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.

# Certain confidential portions of this Exhibit were omitted by means of marking such portions with brackets (“[****]”) because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.

## This certification is deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 9A. Controls and Procedures